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CAPILLARY ELECTROPHORESIS AS A HIGH THROUGHPUT SCREENING 
TOOL FOR PROTEIN PROTEIN INTERACTIONS 
by 
Jing Nie 
Chair: Robert T. Kennedy 
Protein Protein Pnteractions (PPIs) are key players in all aspects of cellular 
functions. In depth understanding of PPIs and discovery of PPI targeted therapeutics 
requires facile and user-friendly PPI analysis. Capillary Electrophoresis (CE) is a 
valuable tool to study affinity bindings including PPIs. Fast separation speed and 
nanoliter sample consumption suggest great potential for CE based High Throughput 
Screening (HTS). To explore CE as a PPI analysis and HTS tool, we have developed a 
CE based assay for Heat Shock Protein70 (Hsp70) and its co-chaperone Bcl2-Associated 
Anathogene 3 (Bag3).  
An Affinity Probe CE (APCE) method was developed for full length Hsp70 and 
Bag3 extracted from cell culture. In this assay, Hsp70 was labeled with Alexafluor® 488 




as Hsp70 and complex peaks resolved and detected using Laser Induced Fluorescence 
(LIF).  
On a commercial instrument, the CE assay takes 6.5 min per run which allows a 
sample throughput of 220 tests per day. In a pilot screening, ~3300 small molecule 
library compounds were tested for novel inhibitor discovery. By comparing CE assay’s 
performance to an existing high throughput screening platform Flow Cytometry Protein 
Binding Assay (FCPIA), CE showed much better specificity as evidenced by lower 
hitting rate and higher confirmation rates in confirmatory tests.   
Fully realizing the low sample consumption benefit of CE based HTS requires 
low volume sample manipulation capability. Segmented flow microfluidics is an 
emerging technique that allows nanoliter to picoliter volume samples to be manipulated 
and coupled to CE analysis. In the second half of this thesis, unit operations of segmented 
flow microfluidics, namely splitting and reagent addition were developed to fulfill the 
need to aliquot and add reagent to nanoliter segmented flow samples. Based on these 
results, future work would be to integrate the CE separation with these sample 











The objective of this thesis is to explore Capillary Electrophoresis (CE) as a High 
Throughput Screening (HTS) Tool for Protein Protein Interactions (PPIs). 
Protein protein interactions control almost every aspect of cellular functions, and 
represent exciting opportunities for drug discovery. Targeting PPIs, nonetheless, is 
challenging
1
. And pursuing this “less paved road” entails facile and user-friendly assays 
that can be used to characterize validated targets as well as access drug candidates’ 
capabilities in modulating these PPIs.  
CE has great potential in fulfilling this need. Advantages of CE as compared to 
other PPI analysis include direct binding information, immobilization free, no limit on 
protein sizes, tolerance of impurities, low sample consumption, generic methodology 
development, multi-parameter readout, automation with commercial instrumentation, etc. 
These have been well demonstrated through antibody-antigen binding, DNA-protein 
binding and many other CE based affinity studies
2
. So far, these promises are yet to be 
fulfilled for protein-protein interactions. The technical bottlenecks such as protein 
adsorption and sensitive detection still need to be overcome. 
In this work, we used a potential cancer target, Hsp70 (Heat Shock Protein 70) 




effectiveness of CE assay in PPI analysis. In developing a CE assay using full length 
recombinant proteins, we investigated the multiple facets of PPI assay development for a 
real world protein binding system. By doing so, we were able to address multiple 
challenges that were not previously addressed in CE based PPI studies.  
High throughput screening is a key step in modern drug development pipeline. 
For PPI drug targets, HTS is very valuable since many traditional enzyme inhibitor 
development strategies are not directly applicable to PPI modulator discovery. HTS, on 
the other hand, offers a systematic way to discover active chemical entities from large 
chemical libraries. From the point view of assay development, HTS places most strict 
demands on data quality, system robustness, cost and analysis speed. CE features high 
separation efficiency, automation, minimum sample consumption, fast speed and 
parallelization, which provides a very attractive alternative for existing HTS platforms for 
PPI targets. To simply demonstrate, we worked on speeding up the CE assay for Hsp70 
and Bag3 and adapted it to a HTS friendly format. In comparing to an existing PPI 
screening platform, Flow Cytometry Protein Interaction Assay (FCPIA), we attempt to 
answer a few key questions in pushing for CE based HTS: 1) what are the true benefits in 
using CE as opposed to available technologies; 2) are the benefits significant enough to 
justify the efforts involved in doing so; 3) what can be done to make CE more amendable 
for routine HTS analysis and what remains to be done.   
TAS (micro Total Analysis Systems) based on microfluidic principles is bound 
to revolutionize chemical analysis by miniaturizing, integrating and automating analytical 
instrumentation.
3
 Capillary electrophoresis is the staple of “on-chip” analysis, as 




advantages of both microfluidics and CE requires “unit operations” that allows robust 
nanoliter volume liquid handling and easy interface to other functionalities. In the second 
half of this thesis, segmented flow microfluidic unit operations, such as sampling and in 
drop chemical reactions are developed. 
With the studies described in this thesis, we strive to pave the road towards facile 
CE PPI analysis and adapting it to HTS friendly format. With technological advancement 
and further demonstrations, we believe CE will be widely recognized as a powerful and 
yet practical tool for PPI analysis and make a significant addition to the toolbox of 
biological and medicinal researches.  
 
Capillary Electrophoresis 
Electrophoresis refers to the motion of charged particles or molecules relative to 
the fluid media under the influence of an external electric field. The velocity of the 
moving particle relative to the fluid the particle is suspended in is determined by the 
strength of the electric field and the electrophoretic mobility of the particle, which is 
defined in the following equation, where    is the effective mobility,          is the 
relative velocity and E represents the electric field (V/cm): 
   
 
 
             Eq. 1-1 
Electrophoretic mobility is characteristic of the property of the particle itself as 
well as the fluid environment as approximated from the Debye-Huckel-Henry theory: 
   
 
    




where q is the charge of the particle, is the viscosity of the fluid media and r is the 
Stokes’ radius of the particle. 
Ever since Michaelis observed proteins migrate to their isoelectric points under an 
external electric field in 1909
4
, the  principle of electrophoresis has been widely applied 
in a myriad of electrophoresis separation techniques, among which are polyacrylamide 
gel electrophoresis (PAGE), sodium dodecyl sulfate (SDS)-PAGE and Isoelectric 
focusing (IEF). These electrophoretic separation techniques are not only ingenious in 
design and very powerful, but also inexpensive and user friendly. Decades after their first 
appearances, these techniques remain the staple of biochemistry and molecular biology 
laboratories. 
Another milestone in the development of electrophoretic separation techniques is 
Capillary Electrophoresis (CE)
5
.  What have been limiting the performance and analysis 
speeds of traditional electrophoresis separation are the convectional distortion of the 
analyte bands and excessive Joule heat in free solution and slab gel electrophoresis. 
Performing electrophoresis separation in a narrow bore fused silica capillary with inner 
diameter (i.d.) ranging from 5 to 200 m greatly reduces convection and enhances heat 
dissipation. As a result, the separation efficiency and analysis speed of electrophoresis 
has reached an unprecedented level. 
Following the pioneering research in late 1970’s and 1980’s, CE has evolved into 
a big collection of different separation modes. These include capillary zone 
electrophoresis (CZE) which is also known as free-solution CE (FSCE), micellar 
electrokinetic capillary chromatography (MEKC), capillary isoelectric focusing (CIEF), 




capillary isotachophoresis (cITP). These various modes of capillary electrophoretic 
separation have been applied to almost every class of analytes, from inorganic ions, small 
organic molecules, to nucleic acids, peptides, proteins and higher order structures. Even 





Figure 1-1. Schematic drawing of (A) CZE setup with Laser Induced Fluorescence (LIF) 
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Among different CE modes, Capillary Zone Electrophoresis (CZE) is the simplest 
and most commonly used one. In a CZE experiment, the separation capillary is firstly 
filled with buffer solution, which is also known as the background electrolyte (BGE). A 
sample plug is introduced from the capillary inlet and a high voltage is applied across the 
separation capillary. Different components in the sample zone are carried towards the 
detection point driven by Electroosmotic Flow (EOF) while being resolved into 
individual bands based on their differences in electrophoretic mobility (Figure 1-1A). 
Electroosmotic flow is a key concept in CE and plays a very important role in CE 
method development. According to electrostatic double layer theory, when a surface is in 
contact with electrolyte solution, an electric double layer is formed at the solution/solid 
interface. Bare silica capillary is highly negatively charged due to very acidic silanol 
groups, which attract a layer of positively charged counterions that move when electric 
field is applied, dragging the bulk solution along, thus creating a net flow towards the 
cathode end of the capillary (Figure 1-1B), namely electroosmotic flow. The relation 
between electroosmotic flow velocity      and external electric field E is given by: 
                     Eq. 1-3 
and      is the electroosmotic mobility. In CZE, the apparent mobility      that is 
measured for certain molecules are actually the sum of the electrophoretic mobility    as 
described in Eq. 1-2 and the mobility due to electroosmotic flow (    ): 
                         Eq. 1-4 
The significance of EOF in CE separation is three folds. Firstly, the direction and 




highly negatively charged under most pHs thus EOF is high (higher than the effective 
electrophoretic mobility of most charged molecules) and towards cathode so that neutral 
as well as negatively charged molecules that migrate against EOF can all be effectively 
separated and detected in the same run together with cationic species. However, more 
often than not, EOF is purposely suppressed or even reversed depending on the analyte 
and application. As an example, surface modification is commonly employed to reduce 
protein adsorption in CE based protein separations, and surface modification methods 
often reduces the EOF, sometimes to near zero. In the absence of the “electric-driven 
pump”, both cationic and anionic analytes cannot be analyzed and detected in a single run 
and the separation speed is usually low.  
Secondly, EOF has a plug shape flow profile. The implication of this is that 
comparing to chromatography separation where pressure driven flow with parabolic flow 
profile is the case, in CZE, diffusion is almost the single source of dispersion contributing 
to band broadening, provided factors such as Joule heating, injected sample plug width 
and adsorption are well controlled or inconsequential. So in ideal situations: 
   
     
          
       Eq. 1-5 
where    is the variance of the zonal peak of analyte  ,    is the diffusion coefficient and 
   is the effective separation length. This also suggests that unlike in HPLC where 
increasing flow rate result in loss in efficiency primarily due to the mass transfer limit, 
increasing analysis speed in CE by increasing EOF does not pay the same price. Thus, the 




injection band and the ability to apply high electric field without causing heat dissipation 
problem.  
Finally, EOF phenomenon rises from surface charges, thus it is highly sensitive to 
surface property change. In CE practice, EOF is commonly used as an indicator of 
surface fouling when change in EOF is observed. Although EOF is not a must for 
successful CE separation, stable and reproducible EOF is indispensible for a method to be 
robust. 
As mentioned above, sample injection for CZE is also of great importance 
because the size and shape of the injected sample plug determines both the separation 
efficiency and sensitivity. Both hydrodynamic (using pressure, vacuum or gravity) and 
electrokinetic (utilizing voltage and EOF) injection schemes are widely used and have 
their respective advantages and disadvantages. For example hydrodynamic injection does 
not cause injection bias against lower mobility molecules while electrokinetic injection 
does not require additional hydraulic system which eases system integration and 
automation.  
Most commonly used CZE detection modes are UV, Laser Induced Fluorescence 
(LIF), electrochemical detection and Mass Spectrometry. By far, LIF is the most sensitive 
detection method for CE.
6
 The sensitivity of LIF comes from the fact that fluorescence 
detection is not pathlength dependent. Tightly collimated and high intensity laser beams 
are excellent light source for exciting fluorophores inside a narrow bore capillary. The 
limit of detection (LOD) of LIF can reach as low as pM or even better. One limitation of 
LIF detection is that most analytes of interest are not natively fluorescent and fluorescent 




reactions targeting specific functional groups being available through commercial sources, 
fluorescent tagging has becoming less of a limiting factor in CE-LIF method 
development. The majority of studies described in this thesis use LIF. Other detection 
schemes will be described in more detail when encountered. 
 
Capillary Electrophoresis in Affinity Studies 
The common themes of all separation techniques are purification, identification 
and quantification of individual analyte. In these areas, different separation methods, 
either chromatographic or electrophoretic has been very successful and widely used. It is 
less well known that separation techniques can also be used to study affinity interactions. 
And this potential is yet to be tapped with the advancement of biology and ever 
increasing need for techniques that characterize affinity interaction between bio-
molecules. 
Different molecules can be separated from each other through a broad spectrum of 
physical and chemical properties, such as size (size exclusion chromatography and gel 
electrophoresis), ionic character (ion exchange chromatography), hydrophobicity 
(reversed phase liquid chromatography), charged to size ratio (CZE), and so on. When 
interacting molecules co-exist in the sample, these properties often changes upon binding 
reversibly or irreversibly, which can be reflected as changes in their separation behaviors, 
such as peak shape change or retention/migration time shift.  
Asymmetric peaks can be a nuisance if better identification and quantitation is the 




suppressed as exemplified by SDS-PAGE based protein separations. On the other hand, 
this phenomenon can be very useful in detecting affinity interactions. Specific to CZE 
based affinity studies, which separate molecules based on their differences in 
electrophoretic mobility, binding event can be detected as mobility shift. And this 
mechanism has been successfully applied in studying various ligand - receptor binding 
systems, such as metal ion - protein binding, small molecule - protein binding, antibody - 
antigen binding, peptide/protein - DNA binding, Aptamer - target binding, etc
7
.  
Despite the big variety of analytes and the existence of a large array of special 
separation modes, the majority of affinity analysis using CE falls into two general 
categories: equilibrium and non-equilibrium. In equilibrium modes, ligand molecules are 
added to the background electrolyte, which retard or speed up the migration of the 
receptor molecules relative to the BGE
8
 (Figure 1-2A). During separation, the receptor is 
always in equilibrium with the ligand because the ligand concentration is constant across 
the full length of the capillary. The amount of mobility change due to binding is related to 
the concentration of binding partner present in the BGE as well as the binding strength, as 
described in Eq. 1-6. 
   
   
       
             Eq. 1-6 
   : mobility change of receptor, in cm
2 V-1 S-1 
[L]: Ligand concentration 
  : Binding constant 
   




Non-equilibrium methods, as compared to equilibrium methods, operate under the 
conditions that equilibrium is not maintained during separation. Taking Affinity Probe 
Capillary Electrophoresis (APCE)
9, 10, 11, 12, 13
 as an example, the ligand in this case is 
fluorescently tagged with a fluorophore and used as the affinity probe. A mixture of the 
affinity probe and its receptor is introduced as a sample plug as in normal CZE 
experiment. During separation, ligand, receptor and the affinity complex with different 
mobility are resolved into separate bands (Figure 1-2B). However, the separation buffer 
is free of either ligand or receptor, so during the separation process, as the sample zones 
of all three species are pulled apart, the local concentrations change, which breaks the 
equilibrium and result in the dissociation of the complex. As in equilibrium methods, for 
a single molecule at a specific time point, the mobility change due to binding is affected 
by the binding strength (relative time that this molecule spend as a free molecule and as a 
complex) and the local concentration of its binding partner. In contrast to equilibrium 
methods, the mobility difference between the complex and the free molecule also plays a 
significant role, which essentially requires sufficient separation power to resolve the 
complex from the free. In APCE, the binding event is eventually detected as part of the 
fluorescent signal of the affinity probe shifting away from its intrinsic migration time 






Figure 1-2. Illustration of (A) affinity CE. Receptor is labeled and ligand is added to the 
background electrolyte. Migration of labeled receptor is retarded when ligand is present 
in the BGE. (B) APCE. One binding partner is labeled as the affinity probe. CE 
separation of affinity probe and its binding partner results in a complex peak that is 
detected in the fluorescence detection mode. 
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Equilibrium methods and non-equilibrium methods have their respective 
advantages and limitations. Different separation modes can be chosen for specific 
applications. Equilibrium methods are more successfully applied in studying interactions 
between relatively small molecules (or metal ions) and bigger bio-molecules such as 
proteins. One practical consideration is that adding big molecules such as proteins in the 
separation buffer consumes a lot of material, which is not cost effective in many real 
world applications. Equilibrium methods heavily rely on accurate mobility measurement 
to determine binding parameters. However, often times, varying the ligand concentration 
in the separation buffer affects the magnitude of EOF. If both the electrophoretic mobility 
and the EOF mobility changes, and the contribution of EOF mobility change cannot be 
easily corrected for
14
, the correlation between migration time shift and binding will be 
obscured and this approach will be out of favor. 
 On the other hand, non-equilibrium methods are easy to do and the sample 
consumption is kept at minimum. The limitation though, is that these methods require 
sufficient resolution in order to be effective, which is not always a trivial matter since 
binding does not guarantee large change in electrophoretic mobility. With transient 
binding systems, the separation process becomes a non-linear system where simple 
models fail to predict the exact separation outcomes and data interpretation is less 
straightforward
15
. This suggests the need for more theoretical works to elucidate the 
correlation between binding parameters and separation results. 
Over the years, many different separation methods have been successfully 




review articles covering this topic
2, 16, 17, 18
 can be referred to if interested, and the details 
will not be repeated here. In this work, we exclusively use APCE due to low sample 
consumption and easiness of implementation.  
 
Protein Protein Interaction 
Protein protein interaction (PPI) is the non-covalent interaction between proteins 
and protein subunits. Multitudes of intermolecular forces, including electrostatic 
interaction, hydrogen bonding and hydrophobic interactions, are all key participants of 
the binding process. Compared to the deep enzyme substrate binding pockets, protein 
interfaces are much larger in size and more flat. PPI can be either stable or transient. 
Interactions between antibody and antigen, and the interactions that hold protein subunits 
together are good examples of stable PPIs. Many PPIs are transient, i.e. the binding is 
dependent upon conditions and the complex form cannot be isolated using 
immunoprecipitation or far-western blotting because complex formation is reversible. 
Early protein research mostly focused on individual proteins. Recent advances 
have shown that most proteins do not act in solitude but interact with other proteins to 
form complexes. The tens of thousands of proteins encoded in the human genome interact 
with one another and form a vast network of “interactome”
19
, which are responsible for 
the regulation of all aspects of cellular processes, including DNA replication, 
transcription, translation, signal transduction, cell cycle control and metabolism.  
PPIs allow targeting of specific disease pathways and represent exciting 
opportunities for pharmacological intervention and drug discovery
1, 20, 21, 22




already evidenced by the success of therapeutic antibodies that target PPI involving 
disease pathways. Therapeutic antibodies have excellent properties: they are highly 
specific for their molecular targets and can be engineered to be stable in human serum. 
However, antibodies only target extracellular receptors and are lack of oral bioavailability. 
The large space of intracellular protein–protein systems has yet to be explored, which 
have been of great interest to small molecule drug development.  
Despite these interests, PPIs were previously considered to be “undruggable”. 
Recent successes, though, have clearly shown that potent and selective modulators can be 
identified. More than 50 inhibitors of PPIs have been reported in the literature and some 
have low nanomolar potency and are achieving clinical success. And with this growing 
appreciation comes an undeniable need for new and potent PPI modulators. As more PPIs 
come into focus, demand for fast and facile PPI analysis is growing.  
 
Protein-Protein Interaction Analysis  
Protein protein interaction has many measurable effects
23
, such as change in 
allosteric properties, substrate channeling, formation of new binding site, size increase, 
etc. These changes can all be useful mechanism in developing PPI assays. However, PPIs 
are highly diversified and methodologies established for one specific PPI may not 
transfer smoothly to a different target. Developing a new assay for every emerging PPI 
target can be a daunting task for individual researchers and early drug discovery. In 
addition, these effects may not be specific to PPI and compounds that alter these 
properties may have no impact on PPI itself. In this light, approaches that offer generic 









Protein binding results in mass and 







Binding with another protein causes 
retardation in sieving through the gel 







Resolving complexes and free proteins 
based on size difference. 








In deuterium labeled solution, the acidic 
groups that can be accessed by the solvent 
will have the hydrogen atoms exchanged 
to deuterium atoms. Low resolution 
structural information can be obtained 
from Nuclear Magnetic Resonance 
(NMR) or Mass Spectrometry (MS). 
Protein binding changes protein 
conformation and surface accessibility. 
Binding/no binding, 
structural information 





Similar to H/D exchange, cross linking 
happens to solvent accessible reactive 
sites and freeze the binding proteins in the 
bound state. Cross-linking site 
information can be identified taking 
proteomic analysis approaches. 
Binding/no binding. 




Using soft ionization techniques such as 
nano-ESI coupled to MS, protein 
complexes can be detected as mass to 







Mobility (charge to cross section area 
ratio) is measured as gas phase ions fly 
through a drift tube filled with carrier 
buffer gas.  
Binding/no binding. 










NMR measures PPI’s effect on the 
chemical shift of H and C atoms. 
Binding/no binding, 





Small and fluorescent molecule will 
acquire a much slower rotation rate in the 
solution and a greater retention of 
polarization in the emission light.   
Binding/no binding, Kd 






PPI induces protein conformation and 
FRET efficiency change 
Binding/no binding, Kd 







Interacting protein pair are immobilized 
on two different beads, which when 
brought to proximity by binding, produces 
chemical luminescence signal. 
Binding/no binding, Kd 





One protein immobilized on polymer 
bead. Binding protein is fluorescently 
labeled and the binding is detected by 
measuring bead associated fluorescence 
by flow cytometry (Figure 1-3 A). 





Refractive index change upon protein 
binding to the surface immobilized 
interacting protein. 
Binding/no bindng, Kd, 





Using thermodynamic parameters to 
determine interactions in solution. Most 
often used to study the binding of small 
molecules to larger macromolecules. 












SEM image of protein complexes. Structural information. 
 





Previously, many analytical methods have been developed to characterize PPIs. 
Most commonly used ones are listed in Table1.  
Some of the listed methods are separation based. The method development is 
relatively straightforward, and data quality is considered to be high. Concerns with 
separation based methods are protein consumption and analysis speed. 
 
 
Figure 1-3. Schematics of how (A) FCPIA assay and (B) SPR works to detect PPI. 
 
Fluorescence and chemiluminescence based methods are widely used for PPI 
analysis. The sensitivity is high and these platforms are compatible with micro-titer plates 
for rapid analysis of large sample sets. Limitations of these approaches, though is that 
















Mechanisms other than binding can affect the signal intensity, and lead to false-positives 
and false-negatives. Labeling is another concern with fluorescence based methods. If 
labeling blocks the allosteric or binding site, affinity and response to inhibitors will 
change.   
Surface Plasmon Resonance (SPR, Figure1-3B) is a very popular technique used 
to study protein protein interaction. It is label free and very useful in kinetic 
measurements. One drawback with SPR is that is involves immobilizing one of the 
binding proteins to a metal surface. Immobilization potentially blocks the binding sites of 
proteins and it is unrealistic to assume surface bound proteins behave the same as in free 
solution. Refractive index measurement cannot differentiate binding and non-specific 
adsorption. SPR is also costly compared to many alternative methods. Immobilization 
steps typically requires large amount of proteins to start with.  
If structural information is desired, X-ray crystallography, Nuclear Magnetic 
Resonance (NMR), Scanning Electron Microscopy (SEM) and Mass Spectrometry based 
methods will be the methods of choice. Nonetheless, these methods require substantially 
more proteins and a lot of expertise, which may turn out to be overkill if only binding 
strength information is needed. 
 
High Throughput Screening 
High-throughput screening (HTS) is commonly used in drug discovery and 
relevant fields of biology and chemistry
42
. Using robotic liquid handling devices and fast 




or pharmacological tests. Through this process one can rapidly identify active compounds, 
antibodies or genes which modulate a particular biomolecular pathway. The results of 
these experiments provide starting points for drug design and for understanding the 
interaction or role of a particular biochemical process in biology. Typically, 10,000 tests 
per day and above are called high throughput. Ultra high throughput refers to over 
100,000 tests per day.  
For protein-protein interaction studies, HTS is highly valuable and can be used for 
multiple purposes, such as identifying novel protein-protein interactions
19
, drug screening 
against pathogenic PPI pathways, finding molecular mechanism and new use of existing 
drugs, and so on.  
Currently, fluorescence based methods, such as fluorescence anisotropy, FRET, 
and FCPIA are the work horses for PPI targeted drug screening, primarily due to the 
superior sensitivity and easy interface to robotic sample handling and high-density miro-
titer plate format. However, very few of the known PPI inhibitors were discovered 
through HTS. More specific assays that are less subjective to false-positives and false-
negatives while still maintaining the HTS-friendliness are clearly in need to realize the 
true potential of HTS. 
 
CE Based PPI Analysis and HTS 
In principle, CE has many advantages as a PPI analysis tool. Firstly, it doesn’t 
involve immobilization. Many immobilization related problems, such as non-specific 




binding events and interferences are less likely to occur. Thirdly, CE imposes no 
limitation the protein size. This gives CE an edge compared to the many methods that 
have to use smaller peptide fragments, which do not always represent the properties of 
full length proteins. Finally, CE is a free solution separation technique and in principle, 
there is no limit on sample matrix and separation buffer composition. This allows 
physiologically relevant separation conditions to be used that perturb the PPI to the least 
extent.  
 First CE based protein-protein interaction studies was in the early1990’s where 
CE methods were developed to study the binding between Human Growth Hormone 
(HGH) and Anti-HGH antibody
43
, Insulin and Insulin Antibody
10, 11
, Protein A and IgG
44
. 
These early works focused on antibody-antigen binding measurement and CE based 
immunoassays, but the same concepts and techniques are applicable to protein protein 
interaction systems in a more general sense. 
Following the pioneering works on antibody antigen binding analysis and CE 
based immunoassays, a few research works have been done exploring pharmacologically 
relevant PPIs. Using Fluorescence Anisotropy CE (FACE) and APCE, Yang and co-
workers studied Src homology 2 (SH2) domain protein binding.
12
  In this research, they 
showed that transient protein binding events between phosphorylated peptides and SH2 
domain proteins can be quantitatively detected using either CE modes. They also showed 
that fast CE analysis allows rapid kinetic measurements. In another study
13
, they showed 
that multiple peptide-protein complex can be detected in the same CE run, suggesting 




on protein protein binding using fast CE assay, which further suggest that CE assay can 
be used in inhibitor and drug discovery applications. 
These early works proved that CE can be used to study not only antibody-antigen 
binding, but can also be used to study transient interactions with fast dissociation rate. 
Many separation modes were experienced and APCE seemed to be both generic and 
reliable if full length proteins were to be used. Despite the previous efforts, the full 
potential of CE can has yet to be realized with full length proteins and demonstration 
with more PPI targets. 
One of the unmet challenges is protein adsorption. Successful CE separation 
requires the capillary inner surface to be inert and analyte adsorption to be minimized, 
because adsorption consumes analyte and slows down EOF, which in turn compromised 
the reproducibility of the methods developed. 
Protein adsorption process is initiated by electrostatic interaction between the 
positively charged groups on protein surfaces and the negatively charged silanol groups 
on bare silica capillary surface
45
 (Figure 1-4). Through dehydration and enthalpy driven 





Fgiure 1-4. Illustrative drawing of protein adsorption onto bare silica surface.  
 
Correspondingly, protein adsorption prevention strategies follow the guideline of 
minimizing electrostatic interactions, and specific approaches can be categorized into a 
few classes
7
: 1) extreme buffer pHs at which electrostatic repulsion dominates; 2) higher 
buffer ionic strength so the electrostatic attractions are weakened; 3) amine containing or 
zwitterion buffer molecules that compete with proteins for surface adsorption sites; 4) 
surface modified capillaries with surface charges neutralized or reversed. Excellent 
reviews can be found on specific approaches and applications
45, 46, 47, 48
, and the details 
will not be elaborated here. 
In PPI studies, it is inevitable that one or both binding proteins adsorb to the silica 
surface. In those cases, the strategies described above can be used. However, affinity 















conditions have to be gentle to the protein binding system and mimic the in vivo 
environment of these proteins as much as possible. Keeping these considerations in mind, 
extreme pHs, high concentration denaturing molecules and species that interfere with the 
protein binding have to be excluded from the toolbox of CE methodology development. 
In reality, surface modified capillary often turns out to be the most effective if not the 
only effective strategy. 
 
Hsp 70 and co-chaperone Bag3 
Hsp70 (~70 kDa) is a molecular chaperone that helps newly synthesized proteins 
to fold properly and is expressed in response to stress
49, 50
. In the latter role, Hsp70 binds 
to protein substrates and stabilize them against denaturation or aggregation until 
conditions improve. This chaperone broadly shapes protein homeostasis by protein 
quality control and turnover during both normal and stress conditions. Consistent with 
these diverse activities, genetic and biochemical studies have implicated it in a range of 
diseases, including cancer, neurodegeneration, allograft rejection and infection. 
Specific function of Hsp70 is modulated by co-chaperones like Bcl2-associated 
athanogene 3 (Bag3). Bag3 binds the nucleotide domain of Hsp70 with high affinity. In 
cancer cells, the Bag3-Hsp70 complex stabilizes a number of key oncogenes by 
protecting Hsp70-bound substrates from degradation and suppresses apoptosis. Evidence 
has been found that silencing of Bag3 in multiple tumor lines sensitizes the cells to 
chemotherapy. For these reasons, Bag3-Hsp70 complex is a potential PPI drug target for 
cancer. Through this thesis, we use Heat shock protein 70 (Hsp70) and (Bag3) as the 







Figure 1-5. (A) Roles of Hsp70 and Bag3 in anti-apoptotic signaling
51
. Crystal structures 
of (A) nucleotide binding domain of Hsp70; (B) Bag3 and (C) Bag domain binding to the 









Segmented Flow Microfluidics and Nanoliter Liquid Handling 
Although CE injections take only nanoliter samples, at least 10 L initial volume 
is needed in order for injection methods to work, which means over 99.9% of the samples 
are wasted. In high throughput screening, reagent consumption contributes to a big 
percentage of the total cost. While 10 L is acceptable, in reducing sample consumption, 
CE’s potential has yet to be unleashed. 
The challenges in developing assays that work with nano-liter volume samples lie 
in the difficulty in handling these extremely small volumes. Commercially available CE 
instruments are compatible with 96- and 384-well plates with sample volume ranging 
from 10-100 L. With fluorescence readout, 1524-well plates and as low as 1L sample 
can be achieved. However, further increase in array density and decrease in sample 
volume is almost impossible with the multi-well plate format limited by evaporation and 
reagent dispensing technologies. 
Confining nanoliter sample plugs or segments by gas or immiscible liquid has 
recently emerged as a promising alternative to well plate-based screening
52
. As shown in 
Figure 1-6, the sample plugs or droplets immersed in the oil phase act as miniaturized 
reaction vessels and they can be manipulated automatically with the help of microfluidic 
droplet manipulation techniques and a combination of “unit operations”. A full spectrum 
of sample manipulating techniques including sampling, dilution and reagent addition has 
been demonstrated. Many detection schemes, such as fluorescence, electrochemical, 
NMR, MS, enzyme assay and immunoassay have been demonstrated to be effective in 




segmented samples to rapid and highly efficient CE separation
53, 54, 55
, which is a 






Figure 1-6. (A) Examples of droplet manipulations: a. droplet generation through a T-
junction
56, 57





Interfacing droplet samples to CE separation
54




HTS experiment is comprised of multiple steps and a lot of sample handling and 
reagent addition steps are needed in addition to the final readout. We realized that robust 
and easy to interface “unit operation”, such as sampling and reagent addition are needed 
in order to approach the goal of nanoliter HTS assay. Motivated by this thought, we 
developed a sampling device and a reagent injector for nanoliter size segmented flow 









CAPILLARY ELECTROPHORESIS BASED PROTEIN PROTEIN 
INTERACTION ASSAY FOR HSP70 AND BAG3 
Introduction 
Protein Protein Interactions (PPIs) controls virtually every aspect of cellular 
processes and are closely involved in many pathogenic pathways. Better understanding of 
PPIs and development of chemical probes and modulators of such interaction are not only 
actively pursued research topics, but also presents exciting opportunities for drug 
discovery
20, 21, 22
. Meeting these promises, however, requires facile analytical techniques 
that are capable of characterizing various PPIs and provide quantitative information 
regarding binding strength, kinetics, stoichiometry, and so on. 
CE has long been shown to be successful in detecting non-covalent interactions 
and is principally sound for PPI analysis
2, 9, 12, 18
. Through various ligand-receptor binding 
studies, CE based methods have shown great potential in PPI analysis: 1) as a free 
solution technique, CE overcomes non-specific adsorption and potential blockage of 
active binding sites due to surface immobilization; 2) mechanism is binding specific and 
false responses from interfering mechanisms are minimized; 3) extremely low sample 
consumption and high tolerance to protein impurities, which makes CE amendable for 
challenging research and drug development tasks where protein availability and purity 




Previous efforts in CE based PPI analysis focused on answering two questions. 
Firstly, among the various modes of CE that can be used for affinity studies, which 
mode(s) is most favorable. Secondly, although CE has been demonstrated very useful in 
characterizing interactions between antibody and antigen and widely used as a strategy 
for developing fast and cost-effective immuno-assays
10, 11
, is it feasible for other PPIs that 
are more transient in nature. Yang and co-workers were able to demonstrate with a 
peptide-protein binding model that both equilibrium methods and non-equilibrium 
methods can be used, and CE is highly effective in detecting peptide-protein complexes 
that have fast association and dissociation rates.
12, 13
 
Despite these advancements, for CE to achieve widespread application in PPI 
analysis, more effort is needed in developing reliable labeling reactions that are friendly 
with intact proteins and yield stable protein conjugates if LIF detection were to be used, 
addressing protein adsorption that often compromises separation and assay robustness, 
and more successful examples that demonstrate generic methodology development for 
PPI analysis and applications with biologically relevant PPI targets. 
In this work, we attempt to answer these challenges by developing a CE based 
PPI assay for Hsp70 and its co-chaperone Bag3. Heat shock protein70s (Hsp70s) are 
chaperone proteins that assist newly synthesized protein to fold and help to stabilize 
proteins as cells respond to stress
49
. Consistent with these cellular responsibilities, Hsp70 
is implicated in many diseases such as Alzheimer’s and cancer
58
. The specific function of 
Hsp70 is modulated by its co-chaperones, such as Bcl-2 associated Anathogene 3 (Bag3), 
which binds the nucleotide binding domain of Hsp70 with high affinity. Bag3 was found 




process and the mechanism is highly Hsp70 dependent.
59, 60, 61
 Evidences suggest that 
Hsp70 and Bag3 binding is an interesting drug target for cancer.  
With this PPI model system, we experienced ourselves with the key steps towards 
a successful CE assay. Full length Hsp70 extracted from cell culture was purified and 
labeled with Alexafluor® 488. By optimizing the surface modification, we were able to 
address the protein adsorption problem by using a covalently modified capillary. Using 
Affinity Probe CE (APCE), protein complex was detected with good sensitivity and 
reproducibility. The method is further validated by competitive binding and binding 
constant measurement experiments. This method has also been applied as a secondary 
confirmation assay for inhibitors identified from a flow cytometry based assay.  
High Throughput Screening (HTS) is a very useful research tool and an important 
step in modern drug development pipeline. CE separation can be performed in seconds
62
 
consuming nanoliters of samples and less, suggesting great potential in HTS. In this work, 
we also explored the possibility of HTS. By applying pressure during separation, the 
analysis time was reduced to 6.5 min per assay, suggesting a moderate scale screening is 
possible with this approach. Further improvement on separation speed should be 
achievable by adapting the system to fast CE and micro-chip CE separations. 
 
Experimental Section 
Materials.  Alexafluor488 SDP ester protein labeling kit was purchased from Life 
Technologies (Carlsbad, CA). Rhodamine 110 was from Invitrogen (Eugene, OR). 1H, 




purchased from Sigma Aldrich (St. Louis, WO) otherwise noted. Fused silica capillary 
was purchased from Polymicro Technologies (Phoenix, AZ). Commercial surface 
modified CE capillaries, including polyacrylamide (eCAP neutral capillary) and 
polyamine modified ones were both purchased from Beckman Coulter Inc. (Fullerton, 
CA). Buffers were made in deionized water purified by E-Pure water systems (Barnstead 
International Co., Dubuque, IA). 
Protein Purification and Labeling.  Human Hsp70 (HSPA1) was purified as 
described in literature (reference) using a His column, TEV cleavage of the his tag, 
followed by an ATP agarose column. Human N-terminal his-tagged Bag3 was purified 
based on previous reports (reference). Briefly, Bag3 was precipitated by ammonium 
sulfate (0-30% of saturation) followed by a His column and TEV cleavage of the his tag. 
Bag3 was dialyzed overnight into buffer (25mM HEPES, 10mM NaCl, 15mM β-
mercaptoethanol, 0.1mM EDTA, pH 7.6) and subjected to ion-exchange chromatography 
on a Mono-Q HR 16/10 column (GE Healthcare). Finally, Bag3 was purified by size 
exclusion chromatography on a Superdex 200 gel filtration column (GE Healthcare). 
Hsp70 was labeled with AlexaFluor® 488 5-SDP ester according to the supplier’s 
instructions. After labeling, the reaction products were cleaned up gel filtration to remove 
any residual labeling reagents. Protein concentrations are determined by BCA assay. 






Figure 2-1. Alexafluor® 488 SDP ester react with amines to form fluorescent conjugates. 
 
PFOTCS derivatized capillaries. 50 mm inner diameter 360 mm outer diameter 
polyimide coated fused silica capillaries were derivatized using a home built setup 
consisting of a pressure bomb and oil bath that controls temperature (Figure 2-1A). The 
acidic silanol groups on the silica surface are modified covalently with a silanization 
reagent PFOTCS (Figure 2-1B). The derivatization reaction is carried out by pressurizing 
the liquid solvent placed in a stainless steel pressure bomb through the capillary tubing. 
Tank nitrogen (Cryogenic Gases, Detroit, MI) at 30 p.s.i. is used as the pressure source 
for all the steps described in below. Three steps of rinsing and activation: 1) MeOH rinse 
at room temperature; 2) RCA solution (NH4OH:H2O2:H2O v:v:v = 1:1:5) rinse at 120 °C; 
3) 0.1 M HCl rinse at 90°C. Every activation step takes 1 hour. After activation, the 




dry nitrogen flow at 165 °C overnight. 10% (volume percent) PFOTCS dissolved in 
toluene was continuously infused for 3 hours at 120 °C.  After reaction, the derivatized 
capillary was rinsed with toluene and methanol to rinse off residual reactive species. The 
capillary is emptied and further dried in oven at 80 °C overnight. Detection window is 
burned by hot sulfuric acid and the capillary ends were sealed with capillary wax until 
being used.  
 
 
















surface after PFOTCS derivatization. 
Capillary electrophoresis. Beckman Coulter MDQ/PACE capillary 
electrophoresis system (Beckman Coulter Inc., Fullerton, CA) was used in most of the 
experiments described herein unless otherwise noted. Separation cartridge and sample 
storage temperatures were both maintained at 25°C. LIF detection used 488-nm light 
from a 20 mW optically pumped semiconductor Sapphire laser (Coherent, Santa Clara, 
CA) that is coupled to the LIF detection module through fiber optics. Emission was 
filtered by a 520 ± 10 nm band-pass filter. The CE instrument was controlled by P/ACE 
32 Karat Software Version 5.0 installed on a computer. In all CE experiments, the short 
end of 30 cm long capillaries was used corresponding to a 10 cm effective separation 
length. 
Screening of four surface modified capillaries. To determine what surface 
chemistry works the best to prevent protein adsorption, four different surface modified 
capillaries were tried with the same protein samples containing Hsp70 and Bag3 under 
different separation conditions as summarized in the table in below. 
Bonding Separation Buffer Buffer Additive 
None 50 mM Tris 192 mM glycine pH 8.3  None 
Polyacrylamide 40 mM Tris pH8.0 None 
Polyvinyl alcohol 10 mM Phosphate pH7.5 None 
Polyamine 40 mM MES-Citrate pH6.0 None 
PFOTCS 10 mM Phosphate pH7.5 0.01% Tween20 




For all the separation experiments, separation buffers were made fresh daily and filtered 
by 0.2 m membrane filter (GE Healthcare, Piscataway, NJ) to remove particulates. 
Protein samples used were 1 M labeled Hsp70 dissolved in sample buffer (25 mM 
HEPES pH7.5, 5 mM MgCl2, 10 mM KCl, 1mM ATP and 0.2% (w/v) Tween20) to test 
if expected change in peak heights and peak shape could be detected after Bag3 was 
added. In all these experiments, pressure injection at 0.3 p.s.i. for 5 second was used. 
Electric filed was kept at 500 V/cm for all CE experiments. For polyarylamide and 
polyamine modified capillaries, reversed polarity was used. Normal polarity was used for 
all the other capillaries. 
Titration and competitive binding experiments. After optimizing the surface 
modification, the CE method was submitted to a series of tests to evaluate the validity 
and quantitative performance of the CE assay. To determine the quantitative response of 
adding unlabeled Bag3 to Alexafluor 488-Hsp70 (abbreviated as Hsp70-488 from now 
on), a titration experiment was performed using CE-LIF as readout.  In the titration 
experiment, the concentration of Hsp70-488 was fixed at 1 M and unlabeled Bag3 was 
added for multiple times to create increasing Bag3 concentrations. Bag3 concentration 
ranged from 0 to 2.5 M at different increments. 3 electropherograms were obtained for 
each Bag3 concentration. In the competitive binding experiment, 2 M unlabeled Hsp70 
was added to the mixture of 1 M Hsp70-488 and 1 M Bag3. In both experiments, 
protein samples were dissolved prepared in 25 mM HEPES pH7.5 buffer with 5 mM 




Inhibitor screening and dose response studies. 18 compounds were identified 
as inhibitors for Hsp70-Bag3 binding by Flow Cytometry Protein Interaction Assay 
(FCPIA). The developed assay was used as a secondary confirmatory assay for these 18 
compounds. DMSO was used to make 10 mM stock solutions except #18 was dissolved 
in water at 3 mM concentration due to poor solubility in DMSO. In the CE screen, all 18 
compounds were tested at 100 uM final concentration with 1 uM Hsp70 and 1 uM Bag3. 
Free to complex peak area ratio were taken and used as a criteria for inhibitor screen. 
Dose response studies were carried out for CE confirmed inhibitors #9, #14, #16 and #17. 
Analogues of #9 were also studies by dose response studies using the CE assay. 
Data analysis. CE data was analyzed with Cutter 7, which is home-written 
software
63
. Curve fitting and dissociation constant Kd determination was carried out 
using Origin 6.0 (OriginLab, Northampton, MA) which was also used for Dose-Response 
Curves (DRCs) and IC50 determination. Error was reported as ± standard error from the 
average. Origin 6.0 was also used for graphing the data. 
 
Results and Discussion 
Reducing protein adsorption by capillary surface modification. Initial method 
development with bare silica capillary achieved limited success due to protein adsorption 
problem. Two samples, one containing Alexafluor® 488 labeled Hsp70 (Hsp70-488) and 
another with equal concentration of unlabeled Bag3 added, were tested using bare silica 
capillaries and standard separation conditions. In the APCE mode, it is expected that 




488, should decrease and a new peak that correspond to the affinity complex should 
appear. However, as is shown in Figure 2-3A, the Hsp70 peak decreased, but the complex 
peak was not observed. We hypothesized that the missing of complex peak is due to 
protein adsorption, and this hypothesis was confirmed by total fluorescence signal 
measurement and fluorescent microscopy studies (data not shown) that suggests no 
quenching in fluorescence upon adding Bag3 and strong retention of fluorescence species 
on capillary inner surface after Hsp70 and Bag3 mixture was applied. 
Protein adsorption was widely observed with CE based separations and one of the 
consensuses is that surface modified capillaries can be used to effectively counteract the 
tendency of protein sticking to capillary surface. Among the various surface 
modifications that have been reported successful, we chose four different surface 
modifications that are popular in their own categories: polyacrylamide and PVA are 
representatives of neutral and hydrophilic surface polymer coatings, polyamine that 
reversed surface charge, and PFOTCS that is neutral and hydrophobic and used in 
combination with a surfactant Tween20
64
 to generate a dynamic and continuously 
refreshed neutral and hydrophilic surface coating. 
Among the four columns tested, both polyarylamide and PFOTCS were 
successful in detecting expected appearance of complex peak as shown in Figure 2-3B 
and 2-3E. With PVA and polyamine coating, the reduction of Hsp70 peak was also was 
observed with addition of Bag3, but the results were not any superior than bare-silica 
capillary and separation took much longer time. Between polyacrylamide and PFOTCS, 
PFOTCS clearly offers better resolution. Although Tween20 has to be used as a buffer 




intervene with the Hsp70 and Bag3 binding. Eventually, we settled down with the 
PFOTCS column which will be used throughout the rest of this research.  
 
Figure 2-3. Electropherograms’ response to adding Bag3 to Hsp70-488. Comparison is 
made between A. bare silica capillary, B. polyacrylamide capillary, C. polyamine coated 
capillary, D. PVA coated capillary and E. PFOTCS capillary that is dynamically coated 
with Tween20. Black traces represent without Bag3 added, and red traces are with Bag3 
added. 3 second pressure injection at 0.5 p.s.i. and 500V/cm electric field was used for all 
the separations. Except for polyacrylamide and polyamine columns, normal polarity was 
used with 10 cm effective separation length. 
 
























































Method validation. After addressing the protein adsorption problem, we 
subjected our method to competitive binding experiment to validate. In this experiment, 
unlabeled 2 M Hsp70 was added to the mixture of 1 M Hsp70-488 and 1 M Bag3. 
Unlabeled Hsp70 will compete with Hsp70-488 for available Bag3 in the sample. 
Because Bag3 is at lower concentration compared the concentration that is needed for all 
Hsp70, competition frees some Bag3 bound labeled Hsp70. As a result, the amount of 
fluorescent complex decreases and the free Hsp70-488 increases, which is reflected as the 
decrease in complex peak and increase in Hsp70-488 peak. As shown in Figure 2-4, this 
is exactly what we observed empirically. The complex peak with migration time of 3.3 
minute was reduced and free Hsp70 peak became taller. These results further confirmed 
the identity of the two major peaks. 
 
Figure 2-4. Electropherograms of (A) 1 M Hsp70-488; (B) 1 M Bag3 added and (C) 1 
M unlabeled Hsp70 added. Electropherograms in the same row are the same except 




















































Next, we tested the quantitative performance of this method by a titration 
experiment and dissociation constant Kd determination. Previously, the effectiveness of 
this assay was confirmed by qualitative measurements showing the relative peak heights 
and peak areas respond to Bag3 concentration changes as predicted by theory. In 
principle, with LIF detection that responds linearly to concentration change, CE method 
is capable of quantitative measurements as well. To demonstrate, we obtained 
electropherograms with at constant Hsp70 concentration and increasing concentration of 
Bag3. As shown in Figure 2-5, the complex peak increased with Bag3 concentration, and 
the peak area of the complex peak correlates with the Bag3 concentration added 
conforming to a saturation binding model.  
 
Figure 2-5. (A) Titrating Bag3 to Hsp70 cause complex peak to increase and (B) the 
response can be used to quantitatively determine the Kd of Hsp70-488 and Bag3 to be 90 
±17 nM.  
By applying non-linear regression according to equations Eq. 2-1, assuming the 
peak area of complex peak is proportional to the concentration of complex in the sample 









































solution at equilibrium, dissociation constant Kd of Hsp70 and Bag3 is determined to be 
90 ±17 nM. With the same proteins and flow cytometry assay, the Kd was determined to 
be 30 nM. The two values are within the same magnitude. The three fold decrease in 
affinity may be attributed to the fact in the CE assay, Hsp70 is labled, whereas in the flow 
cytometry assay, Bag3 is labeled. Another contributing factor is could be that Hsp70 has 
self-association property. Immobilized Hsp70 is less affected by the self-association of 
Hsp70 causing a decrease of apparent Kd being measured as compared to CE.     
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   : Concentration of protein A at equilibrium 
   : Concentration of protein B at equilibrium 
    : Concentration of protein complex AB at equilibrium 
  : Dissociation constant 
    : Total concentration of protein A. Here the fixed concentration of Hsp70-488 is used  
    
 : Total concentration of protein B, which is the x on the saturation curve 
   
 
: Signal intensity of protein complex. Here we use the combined peak area of complex 
peak and dissociation bridge, which is the y on the saturation curve. 
   Constant that is the ratio of peak area and protein complex concentration at equilibrium. 
   




Small molecule inhibitor confirmation and IC50s. With the method validated, 
we used the CE assay as a secondary confirmatory assay for inhibitors indentified in a by 
the flow cytometry assay. 18 compounds were tested (compound information can be 
found in Appendix A) at 100 M. By taking free to bound peak area ratio, a single 
selection criterion can be established to compare the inhibitory effect of different 
compounds to the control. Since the presence of inhibitor cause complex to dissociate, 
the complex peak will decrease and the free peak will increase if a compound has 
inhibitory effects on Hsp70 and Bag3 binding, resulting in a net increase in free/complex 
peak area ratio. Although either decrease in complex or increase in free can be used as 
selection criterion, taking ratio is more advantageous because it corrects for variations in 
injection volume and long term light source fluctuation. Also, it obviates the need for 
internal standards. 
From Figure 2-6A, compound #9, #14, #17 and #18 were confirmed as inhibitors 
as the free to bound ratios exceeded average + 2.5 SD (standard deviation). As an 
example of confirmed inhibitors, the electropherograms of samples with and without 100 
mM #14 are compared in Figure 2-6B. In this case, addition of #14 lowered the complex 
peak and heightened the free peak. #14 is epigallocatechin gallate, abbreviated as EGCG, 
which is a type of catechin that is most abundant in green tea extracts. EGCG has been 
shown to have multiple theraputic benefits against cancer and neurodegeneration. The 
molecular mechanism is found to be related to the binding and inhibition of Bcl-xl 
proteins and the Hsp90 family. It is not surprising that EGCG also shows efficacy in 
inhibiting Hsp70-Bag3 binding. The IC50 of EGCG is determined to be 14 ± 4 M 





Figure 2-6. A. Free/bound peak area ratios measured by APCE for 18 potential inhibitors 
of Hsp70 and Bag3 binding. Control value is shown with error bars representing 2.5 
times standard deviation from the average of 3 replicates. Asterisk labeled compounds 
were considered to be significant.  B. electropherograms of 1 M Hsp70 and Bag3 with 
and without 100 M EGCG. C Dose response curve of EGCG using CE. 
 
#9 analogue studies. Later on, we used the CE assay for another pharmacological 
study where the structure efficacy relationship was studied for inhibitor #9 (Figure 2-7A) 
using compounds with similar structures. DRC curves of 8 structural analogues (#9A –H, 
identities are specified in Appendix B) were obtained with the CE method as shown in 
Figure 2-7B. Among the 8 compounds, #9C and #9G showed similar efficacy as #9 itself. 
#9A, #9B and #9H showed inhibitory effects only at much higher concentrations. 
Structural analysis indicates that both the core structure, which is the anthraquinone 
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structure and the carboxylic acid group are responsible for the inhibition of Hsp70 and 
Bag3 binding. Agreement was achieved between CE study and flow cytometry data, 
which also confirmed that #9C, G, A B and H are inhibitors and #9C and #9G has best 
efficacy.  
 
Figure 2-7. A. Chemical structure of compound #9. B. DRCs of #9 and its structural 
analogues. 
 
Speed up separation by using pressure. With adequate resolution, the CE 
separation can be sped up by simply apply hydrodynamic pressure across the capillary to 
push the injection plug towards the detection point and force the separation to complete 
in shorter time. Previously, the CE separation was only driven by the electric field. By 
applying 0.5 p.s.i. pressure across the separation capillary, the linear flow rate was 
increased by 6.0 cm min-1. Combined with EOF, which is 3.6 cm min-1 at 500V/cm, the 
increased flow rate allowed the separation to be completed in 3 minutes (Figure 2-8), 
suggesting a moderate scale screening with a few thousand tests should be feasible. 
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Hydrodynamic flow with parabolic flow profile inevitably reduced resolution and 
efficiency. Higher pressure and faster separation with the current system is impossible 
because we found 0.5 p.s.i. was the highest pressure that can be applied before the 
complex peak and the free peak begin to merge, in which case binding information will 
be lost. 
 
Figure 2-8. Comparison of electropherograms of identical sample and similar separation 
conditions except in the experiment shown by the front signal trace, 0.5 p.s.i. pressure 




In this study, we developed a capillary electrophoresis assay that can be used to 
detect protein protein interaction between Hsp70 and Bag3. Full length recombinant 














and are friendly to proteins purified from cell cultures. The CE assay was verified by 
competitive binding experiment. In Kd determination and IC50 measurements, CE 
exhibited good quantitative performance and great potential in pharmacological studies 
such as inhibitor efficacy assessment. By applying pressure during separation, the 








MODERATE SCALE DRUG SCREENING TARGETING HSP70 AND BAG3 
INTERACTION USING CAPILLARY ELECTROPHORESIS 
 
Introduction 
Protein-protein interactions (PPIs) are involved in nearly every aspect of cellular 
life
65, 66, 67
 and have gained attention as potential drug targets for various human 
diseases
68, 69
, and with this growing appreciation comes an undeniable need for new and 
potent PPI inhibitors. Historically however, PPIs have been relatively difficult to target 
due to various factors including large surface areas, relatively flat interfaces, lack of 
natural ligand binding sites, as well as the transient nature of protein complexes
70, 71, 72, 73
. 
High throughput screening (HTS)
22 is highly valuable for challenging PPI modulators 
discovery, but among over 100 PPI inhibitors been identified, very few of them were 
discovered by HTS, and facile and HTS friendly assays are clearly in need to unleash the 
full power and many benefits of HTS. 
Currently, several methods are employed to screen for PPI inhibitors. These 
platforms can be divided into two general classes: platforms that measure small molecule 
binding to one protein partner, and platforms that measure direct disruption of a PPI. The 
first class includes techniques such as NMR, surface plasmon resonance (SPR), 
differential scanning fluorimetry, and various in silico methods. While these techniques 
have been successful in producing PPI inhibitors
71
, they are explicitly designed to find 




platforms that measure direct PPI disruption are a more straightforward approach, and 
this includes techniques such as FRET, fluorescence polarization (FP), flow cytometry 
protein interaction assay (FCPIA) and others. These methods can have significant 
limitations when it comes to protein size and buffer conditions. Other limitations of these 
methods exist in that they can require large amounts of protein/peptide material in the 
case of FP or immobilization of one partner in the case of FCPIA. Due to these 
limitations, we have sought to develop a novel PPI screening platform using capillary 
electrophoresis.  
Capillary electrophoresis (CE) methods have long been shown to be successful in 
probing non-covalent interactions in vitro
8, 16, 18, 74
. Similar to Electrophoretic Mobility 
Shift Assay (EMSA), capillary electrophoresis directly detects binding events by 
resolving charged species from their affinity complex form based on the difference in 
electrophoretic mobility. Unlike EMSA, free solution is often used as the separation 
matrix. In principal, CE is highly feasible for PPI analysis
13
. Compared to many 
platforms that are available, CE does not impose any limitation on protein size nor does it 
require immobilization. High separation efficiency, low sample consumption, fast 
separation, high degree of automation utilizing commercial instrumentation and straight 
forward quantification all make CE attractive for high throughput screening of PPIs
62, 75, 
76, 77
. Realizing this potential, however, requires: 1) Addressing challenges such as protein 
adsorption, labeling of proteins and adequate resolution under non-denaturing conditions; 
and 2) Demonstration of assays for biologically relevant targets. 
In Chapter 2, a CE assay was developed to analyze the binding between heat 




have also shown that this assay can be used as a moderate throughput assay for inhibitor 
discovery and confirmation. In this chapter, we report the first use of capillary 
electrophoresis as a protein-protein interaction screening platform using Hsp70-Bag3 as a 
model PPI. After developing validating the CE based protein-protein interaction assay, 
we screened a pilot collection of ~3300 small molecules. Another using an existing PPI 
HTS technology, Flow Cytometry Protein Interaction Assay (FCPIA) was performed and 
the results were compared head to head with the CE screening to reveal the advantages of 
using CE as opposed to available method.  
Experimental Section 
Protein Purification and Labeling. Human Hsp70 (HSPA1) was purified as 
previously described
78, 79
 using a His column, TEV cleavage of the his tag, followed by 
an ATP agarose column. Human N-terminal his-tagged Bag3 was purified based on 
previous reports
80
. Briefly, Bag3 was fractioned by ammonium sulfate (0-30% of 
saturation) followed by a His column and TEV cleavage of the his tag. Bag3 was 
dialyzed overnight into Buffer A (25mM HEPES, 10mM NaCl, 15mM β-
mercaptoethanol, 0.1mM EDTA, pH 7.6) and subjected to ion-exchange chromatography 
on a Mono-Q HR 16/10 column (GE Healthcare). Finally, Bag3 was subjected to size 
exclusion chromatography on a Superdex 200 gel filtration column (GE Healthcare). 
Hsp70 and Bag3 were labeled with Alexa Fluor® 488 5-SDP ester (Life technologies) 
according to the suppliers instructions on amine reactive probes. Hsp70 was biotinylated 
using EZ-link NHS-Biotin (Thermo Scientific) according to the suppliers instructions. 




Capillary Surface Modification. Bare fused silica capillary with inner diameter 
of 50 m and outer diameter of 360 m is purchased from Polymicro Technologies 
(Phoenix, AZ). The acidic silanol groups on the silica surface are modified covalently to 
reduce protein adsorption. The derivatization reaction is carried out by infusing liquid 
solvent and solutions through the capillary using a home built setup consisting of a 
stainless steel pressure bomb made in house and oil bath for reaction temperature control . 
Tank nitrogen (Cryogenic Gases, Detroit, MI) at 30 p.s.i. is used as the pressure source 
for all the steps described in below. Three steps of rinsing and activation: 1) MeOH rinse 
at room temperature; 2) RCA solution (NH4OH:H2O2:H2O v:v:v = 1:1:5) rinse at 120 °C; 
3) 0.1 M HCl rinse at 90°C. Every activation step takes 1 hour. After activation, the 
residual liquid is purged out of the capillary and the capillary inner surface is dried under 
dry nitrogen flow at 165 °C overnight. 10% (volume percent) 1H, 1H, 2H, 2H-
perfluorooctyltrichlorosilane (sigma, St. Louise, MO) in toluene is continuously infused 
for 3 hours at 120 °C.  After reaction, the derivatized capillary is infused with toluene and 
methanol to rinse off residual reactive species. The capillary is emptied and further dried 
in oven at 80 °C overnight. Detection window is burned by hot sulfuric acid and the 
capillary openings are sealed with capillary wax until being used. 
Capillary Electrophoresis. Beckman Coulter MDQ/PACE was used in most of 
the CE experiments unless otherwise noted. 30 cm of the derivatized capillary was used 
with effective separation length of 10 cm. Capillary temperature was kept at 25 °C for all 
experiments. Separation buffer was 10 mM sodium phosphate pH7.5 with 0.01% Tween 
20 (w:v) as the buffer modifier. All separation buffers were made fresh every day by 




to 18 M   resistivity using a Series 1090 E-pure system (Barnstead Thermolyne 
Cooperation, Dubuque, IA) and filtered by membrane filter (0.2 uM pore size, Watman, 
GE) to remove particulates.  
Separation method consisted of three steps: 1) 1 min rinsing using with separation 
buffer; 2) Pressure/vacuum injection at 0.3 p.s.i. for 5 s; 3) 500 V/cm electric field with 
normal polarity was used resulting in current of 14.0 uA. 0.5 p.s.i. pressure is applied 
during separation to generating a pressure driven flow at the same direction of EOF to 
force separation to complete in 3 min. LIF detection was accomplished using a 20 mW 
optically pumped semiconductor Sapphire laser (Coherent, Santa Clara, CA) as a light 
source coupled to the Beckman Coulter MDQ/PACE LIF detection module through an 
optical fiber. 488 nm line was used and emission light was detected at 520 nm. All data 
was collected by 32 Karat software and exported as ASCII files, which is further 
processed using software written in house
63
. 
Small Molecule Libraries. The MicroSource MS2000 library contains 2000 
bioactive compounds with a minimum of 95% purity. The collection contains 958 known 
therapeutic drugs, 629 natural products and natural product derivatives, 343 compounds 
with reported experimental biological activities and 70 compounds approved for 
agricultural use. The University of Michigan Center for Chemical Genomics (CCG) 
Focused collection library includes ~1000 small molecules with target specific activities 
(Wnt Pathway, Kinases, etc.) as well as natural products. The CCG Biofocus NCC library 
is an NIH Clinical collection that contains ~450 small molecules that have a history of 
use in human clinical trials including some FDA approved drugs. The activity of 




sources including Sigma-Aldrich, Enzo Life Sciences, Cayman Chemical, Acros 
Organics, Alfa Aesar, and MP Biomedicals.  
Screening with Capillary Electrophoresis. Experiments were performed in 96-
well conical bottom PCR plates (ISC BIoexpress). A stock solution of Alexa Fluor® 488 
labeled Hsp70 and unlabeled Bag3 was prepared fresh daily in assay buffer (25mM 
HEPES, 10mM KCl, 5mM MgCl2, 0.3% Tween-20 pH 7.5) so that the final 
concentration of both proteins was 500nM in the assay. Compounds and DMSO were dry 
spotted in plates prior to protein addition using a Moquito liquid handler (TTP Labtech). 
Assay buffer (5μL) was added to each well except for positive control wells that received 
5μL of unlabeled Hsp70. Hsp70-Bag3 solution (10μL) was then added to each well. All 
additions were added using a Matrix Electronic Multichannel pipette (Thermo Scientific). 
Plates were incubated for at least 15 minutes and then analyzed on the capillary 
electrophoresis system.  
High-throughput Flow Cytometry Protein Interaction Assay. The assay 
procedure was adopted from previous reports
81
. In brief, biotinylated Hsp70 was 
incubated with streptavidin coated polystyrene beads (Spherotech) for one hour prior to 
assay for immobilization. A stock solution of Alexa Fluor® 488 labeled Bag3 was 
prepared in assay buffer (25mM HEPES, 10mM KCl, 5mM MgCl2, 0.3% Tween-20 pH 
7.5) so that the final concentration of Bag3 was 30nM in the assay. Assay buffer (5μL) 
was added to each well of a black 384 well plate (Thermo Scientific), followed by 
compound or DMSO addition (0.2μL) using a Biomek HDR (Beckman). Positive control 
wells received 5μL unlabeled Hsp70 instead of assay buffer. Bag3 solution (10μL) was 




than compounds were added using a Multidrop dispenser (Thermo Fisher Scientific).  
Plates were incubated for 15 minutes then analyzed using a Hypercyt liquid sampling unit 
in line with an Accuri®  C6 Flow Cytometer. Median bead associated fluorescence was 
calculated using Hyperview software for each well and data was uploaded to the Mscreen 
database.  
 
Results and Discussion 
Development of CE based PPI assay for Hsp70 and Bag3. The CE method 
used here are slight modified from the method described in Chapter 1. Again, Affinity 
Probe Capillary Electrophoresis (APCE) is used (Figure 3-1A) where one of the binding 
partners is labeled with a fluorescent tag and used as the affinity probe. The binding event 
is detected by resolving the affinity probe and protein complex from the affinity probe 
itself based on the difference in electrophoretic mobility and detecting both peaks by 
laser-induced fluorescence. Because separation breaks the equilibrium, dissociation of the 
complex may occur during the separation, resulting in a “bridge” connecting the complex 
and the free peak. In our experiment, Alexafluor-488 labeled Hsp70 is used as the affinity 






Figure 3-1. A. Illustration of how APCE works to detect protein binding events. B. 





























Using covalently modified the capillary surface and Tween 20 ( 0.01% w/v) as a 
buffer modifier, a dynamic and hydrophilic capillary wall coating that can be refreshed 
during separation and rinsing steps,
64
 effectively preventing protein adsorption and 
providing adequate resolution under gentle separation conditions. With 500 V/cm, 10 cm 
effective separation length and 0.5 p.s.i. pressure during separation, the mixture of 
Hsp70-488 and unlabeled Bag3 results in two individual bands (migration time of 96 and 
122 seconds), which correspond to the complex and the free Hsp70 respectively. 
The CE separation method was submitted to a series of experiments to test its 
validity and quantitative performance. The dissociation constant of Alexafluor-488 
labeled Hsp70 and Bag3 was determined by titrating 0.5 M labeled Hsp70 with 
unlabeled Bag3. The peak area of the complex peak as well as the dissociation bridge 
both increase as a function of Bag3 concentration (Figure 3-2A). Plotting the peak area 
against the Bag3 concentration and non-linear regression according to Eq. 2-1 a binding 
constant of 23±8 nM, which is in good agreement with the 15 nM Kd obtained from the 
FCPIA platform using the same proteins and fluorescent tag. 
 Competition binding experiments with unlabeled Hsp70 were also performed. 
The IC50 of unlabeled Hsp70 was determined to be 0.24 M (Figure 3-2B), which agrees 






Figure 3-2. A. Titration experiments and curve fitting for Kd determination. B. 
Electropherograms showing the inhibitory effect of unlabeled Hsp70 on Alexafluor 488-
Hsp70 and Bag3 binding. IC50 of unlabeled Hsp70 was determined by dose response 
study. 
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IC50: 0.24 ± 0.003 M























Adapting CE for Screening. After validating capillary electrophoresis as an 
effective platform for detecting Hsp70-Bag3 interactions, we sought to test the method in 
repetitive analysis to determine its suitability for a screen. The Beckman/Coulter MDQ 
system is capable of analyzing samples from 96 well PCR plates in series. With our 
finalized method, every CE assay takes about 6.5 min including 1 min rinsing, 5 s 
injection and 3 min separation, which gives an overall throughput of 220 samples per day.  
 
Figure 3-3. CE screen workflow. 
 
The workflow of a screening experiment is shown in figure 3-3. Briefly, library 
compounds were deposited in barcoded 96 well PCR plates by robotic sample handlers. 
Proteins and buffer were added so each final assay contains 500 nM Alexafluor 488-
Bar-coded plates loaded 
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Add proteins and controls 
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Hsp70, 500 nM Bag3 and 20 mM library compounds. Each plate contains 16 control 
samples. 8 negative controls contains DMSO without any compound added. Positive 
controls contains 2 M unlabeled Hsp70. The plates were run by the CE instrument and 
an electropherogram was obtained for each sample. The Electropherograms from each 
plate were further analyzed and peak integration was performed. Instead of uploading all 
the Electropherograms, in the CE screen, peak area ratios (complex/free) are taken and 
used as for inhibitor selection criteria
82
 which are further normalized to control samples 
and uploaded to database. To determine the feasibility of CE as a screening platform we 
determined a Z factor for the assay. For calculation of Z scores, we analyzed one 96 well 
plate with half of them being negative controls and the rest the positive controls. The 
calculated Z factor was 0.78, which is well above a value of 0.5 which indicates an assay 
is acceptable for screening
83
.  
Screening of a small-molecule pilot collection and comparison with FCPIA 
screen. Using these conditions, we screened a small pilot library (~3300 compounds) in 
the CE platform (Figure 3-4A). As a comparison, the same collection was screened using 
another PPI assay, FCPIA (Figure 3-4B). In FCPIA, one protein partner (Hsp70) is 
biotinylated and immobilized on streptavidin coated polystyrene beads, while the other 
PPI partner (Bag3) is fluorescently labeled. The two are then incubated together and 







Figure 3-4. Overview of the primary screening results of A. CE platform and B. FCPIA 
platform. C. Triage breakdown of two screen platforms. 
 
3443 Compounds 
Screened at 20 M
>3SD by Plate 76 Hits
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33 Confirmed (69%) 59 Confirmed (50%)
8 Reconfirmed (57%)
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 Samples were screened at a single concentration (20 μM) in both platforms. 
Compounds that exhibited inhibition ≥ 3 SD from the controls were considered “hits”. 
CE identified 79 primary hits using this cutoff (2.3%), while FCPIA identified 117 (3.4%) 
with only 6 primary hits identified by both platforms (Figure 4C).  Because the same 
nominal proteins and same libraries were used, the low overlap for hits was unexpected. 
This may be due to higher sensitivity of the FCPIA assay, which used a lower Bag3 
concentration. This view is supported by the finding that the CE assay did not detect 
some low efficacy inhibitors such as compound 9 and 17. Another likely factor is that 
protein modification and immobilization play a role in the assay. CE used labeled Hsp70 
and no protein immobilization. FCPIA used labeled Bag3 and immobilized Hsp70. 
Immobilization and labeling may affect the interaction, accessibility of allosteric binding 
sites, and accessibility of protein-protein binding interface.  
 To further evaluate the screen results, hits found by CE were then triaged based 
on activity and raw electropherograms to reduce the number of “real” hits to 48. 
Specifically, Electropherograms of all 79 initial hits were retrieved and inspected. “False 
positives” that were caused by injection failure or abnormal peak shapes were manually 
rejected before further dose-response studies. In this step, electropherograms of 79 
primary hits were retrieved and inspected for abnormal peak shapes. In this step, 31 
compounds were removed from the inhibitor list reducing the number of “real” hits to 48. 
Figure 3-5B and 3-5C are examples electropherograms that were considered abnormal. In 
the case of 3-5B, the signal was very low probably due to injection failure or protein 
aggregation. Whereas in 3-5C, the B/F ratio was low simply because the compound was 




compound peak overlaps with the free hsp70 peak, but it can still be told from the normal 
behaving compound (Figure 3-6A) and be teased out from the list of potential inhibitors.  
 
Figure 3-5. Comparison between the electropherograms of A. normal compound and 
false positives caused by B. injection failure and C. fluorescent compound. 
 






































Figure 3-6. A. Examples of confirmed inhibitors showing inhibition by decrease in 
complex peak and increase in free peak. B. Protein aggreation aggents can be 
differentiated by examining the electropherogram. For haematoxylin, the proteins signal 
for both peaks are gone and sharp peaks correspond to the diffraction of insoluable 
particles were observed. 
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 Dose response screen was performed on the selected compounds and confirmed 
hits were determined based on the fit of their dose response curves (DRC). CE confirmed 
33 hits (69%), whereas FCPIA confirmed 59 hits (50%). Compounds were prioritized and 
repurchased from commercial sources based on activity in DRC and availability (14 
compounds purchased for CE and 18 for FCPIA, with a 2 compound overlap). Upon 
repurchasing, compounds were retested in their original platforms usingDRC.  In both 
platforms 8 compounds reconfirmed, and were then subjected to confirmation in the 
alternate platform. All repurchased compounds that reconfirmed in CE were also 
confirmed in FCPIA, however only 50% of the compounds that showed activity in 
FCPIA were considered hits in CE.  
Compared to the FCPIA platform, CE clearly shows better specificity as 
demonstrated by low hitting rate and higher percentage of primary hits being confirmed 
by DRC and alternative methods. The specificity of CE rises from the fact that CE data is 
more information-rich. Instead of using absolute fluorescence intensity, CE detects two 
peaks and used relative peak area change as the selection criteria. Artifacts that are 
common to fluorescence based assays, such as fluorescence enhancing/quenching agents 
and protein aggregation inducing agents do not affect the CE assay as severely because: 1) 
CE has separation power which simplifies the protein matrix as the fluorescence signal is 
detected; 2) using peak area ratio corrects for factors that affect the two peaks equally; 
and 3) many artifacts can be teased out if alien peaks or abnormal peak shapes are 
observed. As shown in Figure 3-6 A, confirmed inhibitors cause complex peak to 
decrease and free peak to increase. However, protein aggregation inducing agent doesn’t 




modified protein (labeled Hsp70) rather than having both proteins modified for the 
FCPIA (one protein labeled and one immobilized). 
Column lifetime. Unlike fluorescence based methods where discrete samples 
were analyzed through contactless readout, separation based methods involves 
continuously injecting samples onto the separation column where they are analyzed in a 
sequential manner. One question that can be anticipated with separation based screen is 
whether the separation columns can endure large number of samples. In our screen, we 
found the PFOTCS capillaries are stable for at least 500 injections without decline in 
performance. As shown in Figure 3-7A, over 500 injections were made on one column 
and the B/F ratios of control samples were still stable without signs of deterioration. 
Excellent agreement between columns was achieved as shown in Table 3-1.  
 
Figure 3-7. Long term stability of B/F ratios of a PFOTCS column over 500 assays run. 



























Parameters RSDs  
Peak area ratios (n=48)  
on a single column (Figure 3-7) 
Positive controls: 6.9% 
Negative controls: 11%  
Migration time  on the same capillary  
(n=6)  
Complex: 0.67% 
Free: 0.43%  
Migration time  on different capillaries 
 (n=13)  
2.3% (Rhodamine 110 runs when 
new capillaries were first put into 
use)  
Table 3-1. RSDs in peak area ratios and migration times on a single capillary 
and between different capillaries. 
 
Confirmed inhibitors from CE screen. Structures of the confirmed inhibitors 
were shown in Figure 3-8A and their dose response curves were shown in Figure 3-8B. 
Structurally, the majority of CE identified inhibitors has polyphenol type structures 
versus aromatic structures were prevalent with flow cytometry identified inhibitors. In-
depth structure analysis cannot be performed because very limited conclusion can be 
drawn with a small number of inhibitors. With large scale screening encompassing a 
bigger variety of chemicals should better benefit such chemical biology studies and shed 





Figure 3-8. A. Chemical structures of 7 inhibitors confirmed by both CE and FCPIA. B. 
DRCs of the 7 inhibitors shown in Figure 3-7A. 
 













































As a separation technique, CE is widely used and highly advanced. However, as a 
high throughput screening platform for PPI, CE is still in its infancy. Our data suggests 
that a few aspects of this method remain to be improved. The data quality of CE results 
highly depends upon the quality of the separation capillary. We observed peak area ratio 
values drift as the derivatization wears off. This usually occurs after more than 500 
injections. For a screen of a few thousand compounds, it is not a big issue. But for a full 
scale screen, more robust and corrosion resistive surface is highly desired. Fluorescence 
labeling gives best sensitivity. However, labeling related problems, such as multiple 
peaks and possible interference with the binding are all concerns that can be addressed by 
hyphenating CE separation to novel detection schemes. High data quality of CE comes at 
the price of relatively low throughput. Higher throughput requires faster and parallel 
separation, which is proven to be principally sound and practical
84
. An alternative 
approach to increasing throughput is use of microchip electrophoresis. Indeed, chip-based 
electrophoresis instruments are commercially available (Caliper) for HTS; however, these 
instruments are used for enzymatic assays. This work suggests that such instruments 
might be used for PPI assays if the method can be transferred to a chip format. And we 
believe with technological advances and demonstration with more PPIs, CE will become 
more accessible and amendable for routine PPI analysis and large scale high throughput 









SAMPLING FROM NANOLITER PLUGS VIA ASYMMETRICAL SPLITTING 
OF SEGMENTED FLOW 
 
Introduction 
Precise and automated manipulation of small volumes is essential to miniaturized 
analytical techniques.  Segmented flow microfluidics, where samples in the form of plugs 
are separated by an immiscible fluid within a channel or capillary
85
, has emerged as an 
attractive approach to process arrays of samples with fL to nL volumes
86, 87
.  This method 
has been applied in many areas including micro-scale chemical synthesis
88












.   In these applications, use of a second immiscible phase 
helps to compartmentalize samples so that identity and integrity of such small samples 
are preserved with minimal evaporation and chemical cross-talk.  The format is also 
attractive because of potential for high-throughput.  A number of unit operations, 
including mixing, extraction, and reagent addition, have been devised for processing 
samples in segmented flow
52
; however, more plug manipulation techniques are still 
needed to fully tap the potential of segmented flow microfluidics.  In this work, we 
describe a method for removing samples or aliquots from arrays of plugs based on 
asymmetric splitting of segmented flow in a microfluidic device.    




sampling from nanoliter plugs are limited.  One method that has been described is to 
extract aqueous plugs from segmented flow to an aqueous stream, essentially converting 
segmented flow to single phase flow
54, 93, 94
. This conversion enables analysis by methods 
that are compatible with continuous flow, such as capillary electrophoresis; however, it 
also eliminates the advantages of segmented flow because after the oil is removed, the 
samples begin to disperse and dilute.  Another approach for sampling makes use of a 
branch channel to peel daughter droplets off parent plugs flowing through the main fluid 
channel
95
.   By adjusting the pressure at the fluid inlet, daughter droplets of 34-523 fL 
(10
-15 
L) volume can be removed from the parent plugs.  Because this system was devised 
to study effect of confinement on reaction dynamics, many aspects of sampling were not 
explored such as collection of large numbers of plugs.  This device was also not 
compatible with fluorinated oil due to high surface tension, which is a preferred carrier 
phase due to immiscibility with both aqueous and organic solvents.  Sampling from plugs 
has also been achieved by pumping into a bifurcated channel to achieve symmetrical 
splitting
96
.  This approach was used with a hierarchy of symmetrical splits to create an 
array of samples with 1/2
n
 volume where n was the number splits, from a single plug.     
Extending the flow split approach to asymmetrical splitting so that arbitrary 
aliquots could be removed by pumping into channels with unequal flow resistances is 
complicated by the nature of segmented flow.  Specifically, in segmented flow each plug 
creates flow resistance so that the total flow resistance in a channel is dependent not only 
on viscosity of the carrier phase and channel dimensions, but also on the number of plugs 
present in the channel
97, 98, 99
 i.e.,                +       , where the pressure drop 




(            ) and the pressure drop across each of the N plugs (      )100.  Because 
each plug contributes pressure drop, flow resistance and splitting ratio changes as plugs 
are collected in the device.     
A solution to this problem is presented here that was inspired by recent 
fundamental studies of segmented flow.  Stable asymmetrical splitting of plugs has been 
reported by using a fluidic loop structure 
57
.  In this device, plugs are pumped into a loop 
that has unequal arm lengths to define a split ratio.  Because the loop is closed, i.e. the 
arms reconnect downstream, unequal pressures do not build up downstream and stable 
splitting is obtained.  This device is not applicable for sampling purposes because it 
recombines the split flow and therefore does not preserve the separation of split plugs.  
Other studies have shown that plugs flowing parallel to each other in interconnected 
channels can remain isolated by creating high interfacial tension within the contact 
region.
101, 102
  In our system, we take advantage of the control and stability afforded by 
the loop design but, by fabricating posts inside the recombination region downstream of 
the split, create high interfacial tension that prevents split plugs from merging.  This 
device allows sampling from plugs by asymmetrically splitting them and collecting the 
resulting splits into separate capillaries or channels.  This splitting device adds to the 
segmented flow toolbox and should find applications where stable and variable sampling 
from plugs or asymmetrical splitting is needed. 
Experimental Section 




fabricated following standard soft lithography procedures in PDMS
103
.  Briefly, SU-8 
2075 photoresist (MicroChem Corp. Newton, MA) was spin-coated onto a 3” silicon 
wafer (purchased from University Wafer, Boston, MA) at 4000 rpm, pre-baked and 
exposed to UV radiation for 13.3 s (365- nm mercury line, 60 mJ/cm
2
 power, Optical 
Associates, Inc.Milpitas, CA) through a dark field mask (Fine Line Imaging Co., 
Colorado Springs, CO) to crosslink the exposed features, and post-baked before 
employing SU-8 developer (MicroChem Corp. Newton, MA) to develop the remained 
SU-8 photoresist.  The height of the master features was kept 60 µm across the whole 
microfluidic network.  Channel width was 150 µm at the plug generation tee and 
narrowed down to 30 µm at the splitting area.  The width of daughter plug receiving 
channels was 100 µm and plug separation posts were of 30   30 µm square cross-
sections and spaced 30 µm apart from each other.   After casting PDMS over the molds, 
the layer containing channels was removed and derivatizing reagent access holes were 
made by poking a blunt 18-gauge needle into the PDMS.  After plasma bonding with a 
piece of unpatterned PDMS, the sealed device was placed on a hotplate (temperature set 
to 75 °C) for 10 min to enhance bonding.  A 1 mL plastic syringe was used to deliver 
3:100 (v:v) 1H, 1H, 2H, 2H-perfluorooctyltrichlorosilane solution in anhydrous 
hexadecane (both purchased from Sigma Aldrich, St. Louis, MO) into the channels 
through the punched access holes to flush the fluid channels.  This step was repeated 
twice.  Derivatized chips were then put on hotplate (temperature set to 75 °C) for 30 min 
to anneal derivatization. 100/160 and 50/150 silica capillaries (Polymicro Technologies, 
Phoenix, AZ), pre-silanized by 1H,1H,2H,2H-perfluorooctyltrichlorosilane, were inserted 




outlets, respectively.  To finish the fabrication, the devices were encased with PDMS in a 
plastic petri dish and baked at 80 °C in an oven overnight.   
Plug splitting experiment.  Aqueous plugs were generated by merging aqueous 
phase and oil phase at a tee junction fabricated upstream of the splitting channels
104
.  
Food dye diluted with water to1/3 of the original concentration was used as aqueous 
phase for visualization.  For oil phase, 10:1 volume ratio Fluorinert FC-70 (purchased 
from 3M Corporate, St. Paul, MN) and surfactant 1H,1H,2H,2H-perfluoro-1-octanol 
(from Sigma Aldrich, St. Louis, MO) mixture was used.  Flow rate was controlled by 
syringe pumps (Chemyx Inc., Stafford, TX) for both phases.  Pictures showing splitting 
channels were taken by a digital camera (Stylus 1030 SW, Olympus Imaging America 
Inc., Center Valley, PA) through a Nikon inverted microscope (Eclipse TS100, Melville, 
NY).   
Split ratio dependence upon plug input frequency.  Plug input frequency was 
changed by varying the relative flow rate of oil and aqueous phase (1 µL/min total) at the 
plug generating tee upstream of the splitting area.  Four different relative flow rates 0.5: 
0.5, 0.7: 0.3, 0.9: 0.1 and 0.95: 0.05 (oil: aqueous) were used and the plug input 
frequency was about 2.5 Hz, 2.0 Hz, 1.0 Hz, and 0.5 Hz respectively with parent plug 
size of about 3.3 nL, 2.7 nL, 2.0 nL and 1.7 nL.  Split ratios were determined by image 
analysis using ImageJ software.   
Long term stability test and laser-induced fluorescence (LIF) detection.  In 




plug generation and splitting. LIF detection was performed with an epi-illumination 
apparatus
105
.  Instrument control and data collection were performed using LabVIEW 
software written in house (National Instruments, Austin, TX). Data analysis and graphing 
was done by Origin 6.0 software.  
Results and Discussion 
Chip performance.  A photograph of a microfluidic chip used for stable 
asymmetric splitting is shown in Figure 1A.  The chip uses narrowed channels on the 
feed side of the loop to achieve splitting.  Plugs break up at relatively high capillary 
number (        , where  ,  ,and    represent viscosity of the continuous phase, flow 
velocity and interfacial tension, respectively) and greater extension (         , where 
      are plug length and width respectively)
57
.  Based on these considerations, a 
narrowed splitting tee (Figure 4-1B) is used to increase local linear flow rate and elongate 
plugs, so breakup of plugs is more efficient.  By using different lengths of narrowed 
channel on each side of the loop (L1 and L2 in Figure 4-1A), asymmetric splitting is 





Figure 4-1. (A) Photomicrograph of microfluidic device for stable asymmetric splitting.  
Arrows indicate flow direction.  This device has L2/L1 = 1.5 to define the split ratio.  
Flow rates for oil and aqueous phases are both 0.5 L/min in generating the plugs 
upstream (at a tee, not shown). (B) Enlarged view of the narrowed splitting tee showing 
asymmetrical splitting of elongated plug.  (C) Enlarged view of the pressure equalization 
bridge showing no coalescence between streams of plugs of different sizes. 
 
To achieve stable a splitting ratio, the output channels of the splitting tee are 
“shorted” so that the pressure can equalize across the bridge (Figure 4-1C).  As a result, 
the pressure drop caused by plugs that are collected in downstream outlet channels or 
tubing will not interfere with the splitting.  To keep the split streams of plugs separate 
while being able to equalize the pressure, posts are built into the recombination channel 
to keep the plugs from merging and coalescing as they pass by the junction (Figure 4-2C).  
The total length of the bridge is made greater than the length of plugs on both sides to 













otherwise, plugs undergo secondary splitting.  
Controlling sampling ratio.  A loop structure permits the split ratio to be 
controlled by varying the relative flow resistance of channels between the feed side and 
the reconnection point analogous to a parallel electrical circuit
57
.  The volume ratio of the 
two daughter plugs produced on each side of the loop, V1:V2, is proportional to the ratio 
of volumetric flow rates, Q1:Q2, through each side of the loop.  In rectangular fluid 
channels,        , where    is the pressure drop,    is a function of channel height 
and width, and   is the length of the channel.  Provided identical pressure drop across 
both arms of the loop, flow rate ratio should be inversely proportional to the ratio of 
channel length (in our device, the channel length ratio can be approximated as the length 
ratio of the narrowed channels because    is dominated by the narrow portion), that is 
V1:V2 should equal L2:L1. 
To test the system for achieving different split ratios, devices with four length 
ratios in the splitting tee were fabricated (Figure 4-2).  The length ratios (L2:L1) of the 
narrowed bifurcating channels were 1.5:1, 2.0:1, 3.9:1 and 5.6:1, which corresponded to 
the theoretical splitting ratios (V1:V2).   Qualitatively, the observed split ratios increased 
with increasing length ratio as expected (shown in Figure 4-2); however, quantitatively 
we found that the actual split ratios differed from the expected value, especially with 
chips of larger split ratios.  For example, the channel with a length ratio of 5.6:1 
generated plugs with a volume ratio of 34:1.  Volume ratios were estimated from the 
length of the plugs formed, which does not account for meniscus effects; however, this 





Figure 4-2.  Photomicrographs showing microfluidic devices with different splitting 
ratios.  Flow rates for oil and aqueous phases are both 0.5 L/min for all devices.  Length 
ratios of narrowed channels are given above each photograph. 
 
The deviation is attributed to the presence of multiple plugs that coexist inside the 
loop structure, i.e. in the flow path upstream of the pressure equalization bridge, which 
cause additional pressure drop.  Thus, the  split ratio is not solely determined by the 
continuous phase and the split ratio; but, it tends to be higher than predicted because the 
channel (between the splitter and pressure equalization point) that collects smaller plugs 
has more plugs present and therefore creates a higher flow resistance in that channel. 
500 µm
(A)                  L2/L1 = 1.5 (B)                  L2/L1 = 2.0 




Also, the capillary number for the side with longer channel and less flow rate tends to be 
lower, which makes pressure drop caused by a single plug even larger, which could 
further contribute to the deviation. 





















Figure 4-3.  Effect of length ratio (L2/L1) on split ratio, i.e. the ratio of parent to 
daughter plug volume (V1/V2).  Theoretical value is based on the assumption that the 
length ratio defines the split ratio.  The experiment was performed with different plug 
generation frequencies, indicated on the graph, which in turn determined the number of 
plugs in the loop structure at one time.  Chip design was that shown in Figure 2C.  Each 
data point is the average of 3 plugs selected at random with 1 standard deviation used for 
the error bar. 
 
If the deviation in split ratio is primarily caused by the presence of multiple plugs 
inside the loop structure, then the extent of this effect can be offset by lowering the 




present in the loop at one time creating less back pressure.  As shown in Figure 3, as the 
plug frequency is decreased, the split ratio approaches that expected based on the relative 
channel lengths.  When parent plug input frequency is lowered to 0.5 Hz, only the plug 
that is being split is present in the loop and the split ratio becomes close to the expected 
values.  For the purpose of sampling, these results show that sampling ratio can be varied 
by both the loop structure and gap between plugs.   
Long Term Stability. To evaluate stability in sampling ratio, we monitored the 
size of daughter plugs formed while splitting a series of plugs formed upstream.  In this 
data analysis, we assume parent plugs are of regular size so that consistency in daughter 
plug size is indicative of splitting stability.  We chose a chip design that produced 0.3 nL 
daughter plugs from 3.3 nL plugs when plugs were generated at 2.5 Hz for testing (Figure 
4-2C).  Fluorescence signal was monitored at the exit capillary for smaller daughter plug 
for more than 50 min (sample data from 5 replicates is shown in Figure 4-4A).  To 
quantitatively evaluate split stability, plugs at 30 s interval were selected and peak widths 
were plotted against time showing no drift over this period (Figure 4-4B).  The standard 
deviation of 6.3% in peak width indicates good long-term sampling stability and 





Figure 4-4.  Stability of asymmetric splitting.  (A) Fluorescence detection (in arbitrary 
units, a.u.) of series of daughter plugs detected downstream of the split.  Data shown is 
portion of a 50 min experiment using device with design in Figure 2C.  (B) Peak width of 
daughter plugs during a 50 min splitting experiment.  A single plug was measured every 
30 s.   
In contrast, without the pressure equalization bridge (Figure 4-5), the plugs’ split 
ratio rapidly changes preventing control of split ratio.   These results illustrate that the 
pressure equalization bridge is effective at allowing stable asymmetric splitting and 
collection of resulting plugs. 








































Figure 4-5.  Unstable asymmetric splitting without a bridge. (A) Drawing of 
asymmetrical splitting tee used without a bridge to reequilibrate pressure after the split.  
The length ratio is controlled by adjusting both the narrowed region and the capillary 
length ratio of the side arms of the tee junction and the tubing receiving plugs.   (B), (C) 
and (D) show the time evolution of splitting via the asymmetrical tee in a single splitting 
experiment, which indicates inconsistency in split ratio over time. 
Conclusions 
These results demonstrate that the design of Figure 1 allows 1.7 to 3.3 nL plugs to 
be split with fractions from 0.03 to 0.5.  The system allows splitting of thousands of plugs 
with no deterioration over time.  This is in contrast to simpler split designs (Figure 5) 
without a mechanism of re-equilibration of pressure which cannot maintain stable split 














collected into capillaries for storage or further manipulation.  This is in contrast to other 
examples of stable, asymmetric split which were not explored for collection of fractions.  
The capability of sampling from plugs may be useful in a variety of chemical analysis 
procedures.  For example, sample plugs collected from different sources, such as 
sampling probes
53
, capillary separations 
106, 107, 108
, or multi-well plates
55, 92
, could be split 
for analysis by different detectors or assays or to preserve part of a sample after analysis.  
Another application would be in high-throughput screening where an array of test 
compounds, stored as plugs, could be split such that only a fraction is used for a given 








CAPILLARY LIQUID CHROMATORGRAPHY FRACTION COLLECTION 




Capillary Liquid Chromatography (cLC), compared to conventional scale HPLC, 
offers advantages such as reduced solvent consumption, better separation efficiency, and 
facile coupling to mass spectrometry
109, 110
. Despite these advantages, cLC was slow to be 
developed commercially. The advent of ESI-MS has moved cLC to a commonly used 
technique for proteomics
111
. Along with this application, capillary LC instrumentation 
has matured so that now commercial instruments are available that have adequate 





While instrumentation has been improved, it is still difficult to collect fractions and 
perform post-column processing of samples from cLC. A practical obstacle is the 
difficulty in manipulating small volume samples. Capillary LC columns with inner 
diameter (ID) less than 300 um typically operate at < 1 L/min flow rate resulting in 
nanoliter volume fractions, which is far smaller than what conventional fraction 
collection systems can handle. Lack of fraction collection limits the capabilities and 
workflow possible with cLC. It prevents use of slow secondary analytical techniques, like 
NMR, for identifying substances. It also restricts post-column sample manipulation such 




Recently a novel approach to fraction collection from cLC, capillary 
electrophoresis, and microfluidic systems based on segmented flow has been reported
53, 
107, 114, 115
. In this method, effluent from the column is collected as droplets bound by an 
immiscible oil. Using various microfluidic structures, regular droplets are formed from 
column effluent into picoliter to nanoliter volume. The advantage of this approach is that 
it is possible to store and manipulate low volume fractions reproducibly and at high-
throughput. This work has shown several potential uses of fraction collection from 
microscale separations. One cLC application is off-line interface to ESI-MS which 
facilitates “peak parking” in which more time can be devoted to MS interrogation of 
particular peaks by slowing down the flow into the MS
115
. Another report demonstrated 
post-column digestion of proteins by adding enzymes to segmented flow fractions 
suggesting the potential of a novel top-down proteomic workflow at microscale
116
. 
Droplet fraction collection approach has been used for interfacing in 2-D separation at 
microscale
107




In this report we extend the utility of this approach by developing post-column 
derivatization for fluorescence detection of proteins.  Derivatization for fluorescence 
detection is desirable to enhance detection sensitivity, especially in microscale formats 
where UV-absorbance is often inadequate because of short pathlengths. Pre-column 
labeling is problematic for proteins because incomplete labeling of all targeted functional 
groups, for example amines, on a macromolecule results in multiple species leading to 
multiple or broadened peaks for a single protein. Post-column labeling is restricted to 




avoid a high background in detection. Post-column labels must also react quickly to 
prevent extra column band broadening. These twin requirements greatly restrict reagents 
that may be used for post-column derivatization of proteins. 
117, 118
 Here we demonstrate 
collection of separated proteins and subsequent post-column derivatization with the 
related fluoregenic reagent, NDA. In principle, the system can be adopted to other 
fluorogenic reactions with different excitation wavelengths and reaction kinetics. We also 
further evaluate conditions necessary for reproducible fraction collection. Technical 
difficulties such as protein adsorption and droplet data processing are also addressed.  
Experimental 
Chemicals and reagents. Chemicals and solvents were purchased from Sigma 
Aldrich (Saint Louis, MO) unless noted otherwise. 3-(4-Carboxybenzoyl) quinoline-2-
Carboxaldehyde (CBQCA) and naphthalene-2,3-dicarboxaldehyde (NDA) were 
purchased from Invitrogen (Eugene, OR). HPLC grade water and methanol were both 
purchased from Burdick & Jackson (Muskegon, MI). Fused silica capillary was from 
Polymicro Technologies (Phoenix, AZ).  Perfluorinated surfactant Rf-PEG, a 
perfluorinated linear alkane with hydrophilic tail group consisting of polyethylene glycol 
(PEG) repeats, was extracted from Zonyl-FSO100, which is a water suspension of a 
mixture of molecules that share the same structure CF3(CF2)m(CH2CH2O)nH, as described 
elsewhere
119
. Oil phases with additives used for segmenting flow were prepared fresh 
daily. All aqueous solutions were prepared with to 18 MΩ resistivity water purified using 
a Series 1090 E-pure system (Barnstead Thermolyne Cooperation, Dubuque, IA). Protein 
samples were dissolved in water with 3% methanol and 0.1% TFA as 1 mg/mL stock 




Capillary LC separation. Capillary LC columns were packed as described 
elsewhere 
120
. Briefly, a frit was made by tapping nonporous silica (Micra Scientific, Inc., 
Northbrook, IL) into the outlet of a 75 μm inner diameter by 15 cm long fused silica 
capillary. The particles were briefly heated using a butane lighter to sinter them in place. 
The slurry used for packing consisted of 1 mg 3 m C4 Prosphere particles with 300 Å 
pore size (purchased from Alltech, Deerfield, IL) suspended in 1 mL. The capillary LC 
column was packed to 5 cm column bed length at 500 psi using a custom-made pressure 
reservoir.  
A Varian ProStar 210 (Varian, Palo Alto, CA) was used to pump mobile phase. 
Mobile phases were prepared daily, purged with helium and pass through 10 μm pore 
solvent filters (IDEX, Oak Harbor, WA) to remove particulates. Flow rate was 0.5 
mL/min and split to achieve 300 nL/min through the column. Mobile phase A and B were 
water with 0.1% (v/v) trifluoroacetic acid (TFA) and methanol with 0.1% TFA, 
respectively. Injection was accomplished by disconnecting the column inlet from the 
pump and dipping it to a sample solution held in a pressure reservoir through a injection 
valve (Valco, Houston, TX). Gas pressure of 500 p.s.i for 20 s was applied yielding an 
injection volume of 50 nL. For separation, a linear gradient from 0% to 100% B was 
applied over 10 min. Then the system was held at 100% B for 5 min before re-
equilibrating back to 100% A. A Spectra Series UV100 capillary UV detector from 
Thermo Scientific (Foster City, CA) was used to detect protein signal at 214 nm. The 
data was collected through NI USB-6008 data acquisition card (National Instrument, 




Droplet generation and fraction collection. Fractions from cLC were collected 
as segmented flow as shown in Figure 2A. A syringe pump (Fusion 400, Chemyx, 
Stafford, TX) was used to infuse perfluorodecalin with 1% PFO (v:v) and 0.5 mg/mL Rf-
PEG at a flow rate of 0.3 L/min into a PEEK Tee union (C360QTPK4, Valco, Houston, 
TX). The cLC effluent was pumped into another arm of the tee at 90 degrees to the oil 
input. This arrangement resulted in the continuous LC eluent being segmented into 
aqueous plugs separated by oil plugs. The resulting segmented stream flowed out the 
third arm of the tee into  a 1.5 m length of 100 um inner diameter by 360 m OD PFA 
tubing (Upchurch Scientific, Oak Harbor, OR) where they were stored for later analysis. 
For some experiments, a flow injection system was used instead of the cLC to test 
the effect of oil phase content on droplet uniformity and stability. In this system, the cLC 
was replaced with a 6-port, 2-position valve (Valco, Houston, TX) with flow driven by a 
syringe pump (Fusion 400, Chemyx, Stafford, TX) at at 0.3 L/min. The valve was used 
to switch between 50 g/mL myoglobin in 0.1%TFA with 3% methanol and the solvent 
alone. The protein solution also contained diluted blue food color to allow visualization 
of this stream. A 20 cm long 20 mm inner diameter 360 mm outerdiameter fused silica 
capillary at the valve outlet was connected to the tee, replacing the column (Figure 2A), 
for flow segmentation. Resulting droplets were observed using a stereomicroscope (SMZ 
745T, Nikon Instruments Inc., Melville, NY) equipped with a color CMOS camera (EO-
1312C, Edmund Optics, Barrington, NJ. Resulting images were analyzed by Image J (US 




Reagent addition and LIF detection. Reagent addition to droplet fractions was 
performed using a PDMS/capillary hybrid chip (Figure 3A) that was fabricated by soft 
lithography
121
. SU-8 2075 photoresist (Micro-Chem Corp. Newton, MA) was spin-coated 
onto a 3 inch silicon wafer (University Wafer, Boston, MA) at 4000 rpm. After pre-bake, 
the SU-8 coated silicon wafer was exposed to UV radiation for 13.3 s (365 nm mercury 
line, 60 mJ/cm
2
 power, Optical Associates, Inc., Milpitas, CA) through a dark field mask 
(Fine Line Imaging Co., Colorado Springs, CO) to cross-link the exposed features in the 
desired microfluidic pattern. After exposure is the post-bake step and remaining 
photoresist treated with SU-8 developer (MicroChem Corp. Newton, MA). The resulting 
SU-8 features were 60 um high and 150 um, 60 um, and 200 m wide at the droplet inlet, 
reagent addition, and droplet outlet respectively. PDMS was cast over the mold to create 
channels. Access holes were made by poking a blunt 18 gauge needle into the PDMS 
after removing from the mold. The PDMS with channels was sealed to a piece of 
unpatterned PDMS by plasma bonding followed by placing the combined device on a hot 
plate (temperature set to 75 °C) for 10 min. The surface of the channels were derivatized 
by filling the channels with 10:100 (v:v) H,1H,2H,2H-perfluorooctyltrichlorosilane 
solution in anhydrous via the punched access holes. The filled chip was placed on a hot 
plate (temperature set to 75 °C) for 30 min. A 100 m ID by 160 m OD silica capillary, 
pre-silanized by 1H, 1H, 2H, 2H-perfluorooctyltrichlorosilane, was inserted from the side 
of the chip into the microfabricated channel to construct a segmented flow inlet. The 
reagent inlet was made by inserting a piece of bare silica capillary that was 50 m ID by 




Zeus PTFE 38 gauge (approximately 100 m ID and 220 m OD) tubing (Amazon, 
Seattle, WA), which was glued in place using 5 min epoxy.  
To derivatize separated proteins, segmented flow fractions collected from the cLC 
column were pumped at 0.6 uL/min into the reagent addition chip while reagent was 
pumped at 0.3 L/min using a syringe pump (Figure 3A). Derivatization reagent 
consisted of 1 mM NDA and 20 mM mercaptoethanol (BME) dissolved in 30% 
methanol and 70% 100 mM sodium tetraborate buffer at pH 9.3.   
LIF detection
122, 123
 was performed using an epi-illumination configuration based 
on a Zeiss Axiovert 35 M inverted microscope equipped with a 40x, 0.6 numerical 
aperture objective (Carl Zeiss, Inc., Thornwood, NY) and a Photon Technology 
International 814 photometer (Lawrenceville, NJ). The photometer was fitted with 490 ± 
30 nm and 530 ± 30 nm band-pass filters for excitation and emission, respectively. The 
excitation source was 20 mW of 488 nm from an optically pumped semiconductor 
Sapphire laser (Coherent, Santa Clara, CA). The laser was focused onto the PFA tubing 
that is 100 mm in inner diameter and 360 mm in ourter diameter containing derivatized 
droplets. The droplets were pumped past the detection point at 0.9 L/min for detection. 
The reaction time was controlled by the flow rate and tubing length from reagent addition 
to detection point. Instrument control and data collection were performed using 
LabVIEW software written in house (National Instruments, Austin, TX). 
Pre-column derivatization using CBQCA reaction. CBQCA was used to 
derivatize protein samples following the directions of the Invitrogen manual. The reaction 




Data processing. Oil is non-fluorescent, therefore, single point detection of 
segmented flow result in a trace with individual peaks that correspond to the signal of 
aqueous drops and valleys indicating the oil segments. Chromatograms were constructed 
from this data using Igor Pro 6.01 (Wavemetrics, Inc., Lake Oswego, OR). Each droplet 
was identified as an individual peak and peak center and peak amplitude information 
extracted using a built-in macro. Fluorescent signal amplitude was plotted against peak 
center value for chromatograms. Origin 6.0 and Cutter 7.0
63
 were used to plot and 
process chromatograms. 
 
Results and Discussion 
Oil phase additive and droplet regularity. Capillary LC fractions were 
collected using a tee structure (Figure 2A) similar to other reports.
107, 114, 115, 124
 This 
structure has been successfully used in many applications for generating reliable plugs; 
however, we found that when using perfluorodecalin as the oil, proteins in the segmented 
sample caused coalescence of plugs resulting in large and irregular droplets. This is 
illustrated by flow injection data for myoglobin in Figure 1A. These effects are 
detrimental to the separation because: 1) it reduces fraction collection frequency; 2) 
coalescence is variable, which makes downstream reagent injection and quantitation less 
reliable. We hypothesized that protein adsorption to the oil/droplet interface was causing 
this effect. Adsorption of proteins onto the aqueous/oil interface lowers the interfacial 
tension. With lower interfacial tension, droplets tend to be bigger
125, 126
 and coalescence 
occurs more often. Protein concentration varies as a zone elutes from the column so that 




than those at the edges of the peak resulting in variable tendency to coalesce across a 
peak. Adding the fluorinated surfactant Rf-PEG to the oil phase to improved droplet 
regularity and stability (Figure 1B). In the fraction collection experiments described in 
below, PFO was also added. We found PFO alone does not help with the droplet 
generation. However, PFO does seem to improve the performance of reagent injector and 
is thus used in combination with Rf-PEG in the experiments that involve reagent addition. 
 
Figure 5-1. Oil phase surfactant’s effect on droplet regularity: (A) is the droplet trace 
using pure perfluorodecalin as the carrier phase. (B) adding Rf-PEG as a oil phase 
additive, droplets that contain myoglobin at changing concentrationare smaller and the 
size distribution is tighter compared to without. 
 
Separation and fraction collection. When collecting fractions, it is important 
that samples can be collected at a rate that does not broaden peaks. Typically, collection 
of 8 -10 fractions across a single peak is considered to be sufficient to not cause undue 
extra column broadening. Frequently, the number of fractions collected is minimized 
because of the difficulty of manipulating many fractions; however, the segmented flow 







































approach allows facile handling and manipulation of fractions so collecting large number 
of fractions is not cumbersome. 
 
Figure 5-2. (A) Schematic drawing of the fraction collection using segmented flow 
microfluidics. Picture shows the fractions generated from capillary LC that are oil 
immersed droplets stored in a piece of PFA tuing. (B) Chromatogram of reversed phase 
capillary LC separation of 5 protein standards. (C) UV signal trace of the same separation 
but after fraction collection. Pefluorodecalin has abundant UV absorbance at 214 nm and 
maxed out the detector when it reaches the detection point. The valleys are the UV signal 
for the aqueous phase in this diagram. (D) Expanded view of insulin peak from Figure 2 
(C) showing the fractionation of insulin peak into ~30 droplet fractions. 
 
 
To illustrate these points, we compared separations of a test mixture of 5 proteins 




a test mixture of proteins by reversed phase LC at 0.3 L/min with on-column detection. 
Figure 2C illustrates a trace resulting from collecting the same separation in 5 nL 
fractions, corresponding to 1 Hz collection rate (see Fig. 2D) using the system in Figure 
2A. The resulting fractions were pumped through the UV absorbance detector to generate 
the trace. As shown, resolution is preserved despite fraction collection. For example, 
resolution for insulin and cytochrome C before and after fraction collection were both 2.0. 
Figure 2D shows that ~30 fractions were collected across the insulin peak. Thus, it was 
possible to collect well over the minimal 8-10 fractions needed to preserve resolution in 
this sample chromatogram.  
These data also show that fraction size does not change significantly despite the 
change in solvent due to gradient elution. Droplet size was 4.4 ± 0.4, 5.3 ± 0.5 and 5.7 ± 
0.4 nL (n = 5 droplets) at 0%, 50% and 100% mobile phase B respectively. The slight 
increase in droplet size could be contributed to changes in viscosity with methanol 
content. 
Reagent addition and fluorescence detection. For fluorescence detection, it is 
necessary to add derivatization reagent to collected fractions and allow time for reaction 
before detection. Adding reagent to preformed droplets has been demonstrated previously 
86, 89, 90, 103
.  A commonly used approach is to pump reagent continuously from a 
hydrophilic channel or capillary into a hydrophobic tee where sample plugs flow past. 
Reagent droplets that begin to form at the outlet of the hydrophilic channel merge with 
sample droplets (cLC fractions in this case) and rapidly mix due to recirculation effects in 








Figure 5-3. (A) Reagent addition chip design. (B) Bright field image of a functioning 
reagent addition chip. Blue plugs represent the pre-formed fractions. A drop of yellow 
reagent droplet is forming at the outlet of the reagent addition capillary which later 
merges with the incoming blue droplet and form a green droplet after the reagent addition 
step which inters the outlet that is made of a piece of PTFE tubing. Flow rates used here 
are identical to the fluorogenic reagent addition experiments.   
 
We adapted this approach for our work using a PDMS/ capillary hybrid device 
(Figure 3A). In this device, PDMS is used as a mold to allow a fused silica capillary to 
act as a hydrophilic channel for delivering reagent. Teflon capillary collects fractions 
with reagents added as shown in Figure 3A. For this system, fluorogenic reagent is added 
to cLC plugs at half the flow rate of segmented flow.  
Cross contamination may occur in these devices because a portion of a droplet 
passing the reagent inlet can be left behind and then combine with the following droplet. 
Such effects could lead to extra column band broadening in this application. Using 
narrow bore tubing in the reagent inlet helps keep the Peclet number and cross-
contamination low
127
. Carry-over tests using food coloring confirmed the effectiveness of 
















segment results in green colored droplets. As shown in Figure 3B, the yellow reagent 
inlet is barely tainted by the previous blue droplet thus low contamination is carried to the 
next droplet flow by. The lack of extra column broadening or tailing in chromatograms is 
further evidence that cross-contamination is inconsequential with respect to cLC.   
To test this system, we derivatized collected fractions with NDA/BME. NDA has 
been shown to be effective for post-column derivatization in CE separation
91
 and offers 
nanomolar detection limit. From kinetic tests using a fluorescence plate reader, we found 
that fluorescence intensity of NDA/BME derivatives of BSA reached a maximum within 
10 s. The fluorescence signal of the protein-NDA conjugate starts decreasing after 20 s 
which is consistent with results reported elsewhere
130
. Reaction time was controlled to be 
15 s by placing the detector 15 s downstream of the reagent addition tee. Figure 4 shows 
the fluorescent signal trace of segmented flow coupled post-column derivatization with 
NDA reaction and on-line LIF detection. Oil segments are non-fluorescent and appear as 
the signal baseline. Aqueous drops are detected as individual peaks. Fluorescent signal of 
droplets increases with protein collected from the cLC separation so that the 
chromatogram can be reconstructed. Detection limit of BSA was around 2 g/mL, which 
is about one magnitude improvement over UV absorbance detection. Further 
improvement of sensitivity requires is likely possible by using a laser that better matches 






Figure 5-4. LIF signal trace of droplet fractions after NDA reagent is added. 
 
An alternative to fraction collection for analysis is post-column derivatization in a 
continuous flow reactor
131
. In continuous flow post-column reactors, it is important to 
keep the reaction fast and mixing efficient so that not much resolution will be sacrificed. 
Segmented flow eases this requirement because diffusion is limited to within each droplet 
and once the fractions are generated, resolution does not change over time. Therefore, in 
principle even reactions with relatively slow reaction kinetics, such as nano-orange, 
CBQCA, and FQ could be used post-column. Reaction time can be controlled by varying 
the length between the reagent addition point and the detection window. Off-line 
incubation
132
 can be used if the reaction time is on the order of hours. Also, with 
derivatization with segmented flow does not require an on-line system, so collected 





























proteins can be stored and then derivatized later. For example, in these experiments 
proteins were typically derivatized and detected 1-2 h after the fractions were collected.  
Comparison to pre-column derivatization. Compared to post-column 
derivatization, pre-column deriviatzation yields a more complex chromatogram as 
illustrated in Figure 5 which compares chromatograms for 5 protein standards detected by 
UV-absorbance, by UV after pre-column derivatization with CBQCA, and by LIF after 
post-column derivatization with NDA (reconstructed as described in Experimental 
section). With CBQCA pre-column labeling, extra and overapping peaks are found 
(including a large deadtime peak), likely due to excess CBQCA and multiple labeling of 
proteins
133
 making peak assignment and quantitation difficult. On the other hand, the 
post-column approach circumvents the “multiple peak problem” by decoupling 
separation and labeling reaction and using the fluorogenic reaction simply as an indicator 





Figure 5-5. (A) UV chromatogram of 5 protein standards. (B) UV chromatogram of the 
same five proteins that are CBQCA pre-column labeled. (C) LIF chromatogram 
reconstructed from Figure 4(A). 
 
In implementing a post-column reactor, attention is usually focused on reducing 
extra-column band broadening due to dispersion and insufficient mixing. Segmented flow, 
however, provides an alternative to the traditional post-column reactor solutions. 
Operating at a high enough sampling frequency, segmented flow allows resolution to be 
maintained throughout post column fraction manipulations such as fraction collection and 
post-column reaction. Thus, the resolution for insulin and cytochrome C peak from both 




off-line detection. The fluorescence trace also does not have drift associated with the 
gradient, as expected. Figure 5C also shows that relative sensitivities of LIF detection of 
proteins are different from the UV detection. At same protein concentrations, the NDA 
reaction appears to be less sensitive for cytochrome c and carbonic anhydrase. 
 
Conclusions 
In this work, we demonstrate that segmented flow microfluidics can be used to 
collect fraction and perform post-column reaction for capillary LC separation. Taking 
advantage of the capability of manipulating small volumes, we were able to show that in 
the mirofluidic format, we can do the fraction collection at high enough frequency so that 
chromatographic information is preserved. One potential application of this study is the 
quantitation of low abundance proteins, which is hard with other detection schemes. 
Fraction collection offers much flexibility and versatility in post column sample 
processing. Aside from the LIF detection that we demonstrated, we believe this approach 
will enable more applications in capillary based separation techniques, for example, 
multiplexed detection and multi-dimensional separation. Here, we used reversed phase 
LC (figure) separation as a model system. However, the fraction collection and post-
column reaction schemes described here should be easily adapted to other 










CE is an efficient and highly developed analytical method. In this work, we 
demonstrate that CE is indeed a powerful tool for PPI analysis. It offers many unique 
advantages as a screening technology for PPI inhibitors. However, as a high throughput 
screening platform for PPI, CE is still in its infancy. For large scale high throughput 
screening, more work remains to be done: 1) Improve the throughput of CE assays via 
ultra fast separation and parallelization; 2) Full scale screening that allows 
comprehensive assessment of CE’s strength and limitations  
Fast CE Separation 
With current setting based on commercial CE instrumentation, the Hsp70-Bag3 
assay has a throughput of 6.5 min per sample or 220 assays per day. One way to improve 
the throughput would be to speed up the separation. In fact, fast CE is not only 
principally sound, but also practically feasible
74
. With sharp injection band and high 
electric field, separation time can be well within a few seconds while achieving high 
separation efficiency as indicated in the equation below: 
           
 
            




where   is the resolution of molecule 1 and 2,    is the electrophoretic mobility of 
molecules,      is the average electrophoretic mobility,      is the mobility contribution 
from EOF, D is the diffusion coefficient and V is the voltage drop across the separation 
length. From this equation, it is clear higher voltage and faster EOF should are very 
straightforward ways to speed up CE.  
Fast CE separation has been demonstrated both in the capillary and the micro-chip 
format. In either case, small cross-section is the key in keeping the current low when 
voltage is high. So far all successful examples are demonstrated with bare silica capillary 
or un-derivatized glass chips that utilize strong EOF and electrokinetic injection. 
Electrokinetic injection, although very convenient to use, greatly limits fast CE in 
applications that require surface derivatized capillary and suppressed EOF. To overcome 
the dependency of strong EOF, it is necessary to add hydrodynamic injection capabilities 
to the existing fast CE setups for PPI analysis.  
Another approach is to add the vacuum injection to the flow-gated CE system. 
Flow gate is essentially a cross shaped union that is connected to the inlet of the 
separation capillary (Figure 6-1A). Sample is introduced as continuous flow that comes 
in from the opposing side of the cross via another piece of tubing with a small gap (100 
m or less) between the sample introduction tubing and the separation capillary. When 
injection is not performed, the sample flow is directed away towards the waste by an 
orthogonal “gating flow”, which is basically separation buffer that flows at high flow rate 
(100 times higher than the sample flow). During separation, the gating flow will be 




sample outlet and the separation capillary inlet, followed by electrokinetic injection. 
After injection, the sample zone will be cleared by restarting the gating flow to flush 
away the residual samples in the flow gate. Then high voltage can be applied to start the 
separation.  
Initially developed for Capillary LC-CZE 2D separation, flow-gated injection is a 
very useful injection scheme for CE that allows continuous sample introduction and 
efficient injection. To acquire the vacuum injection capability, an easy modification can 
be made as shown in Figure 6-1B. Traditionally, the buffer reservoir at the outlet of the 
separation capillary only provides the electrical contact to the high voltage power supply. 
In the modified system, an air-tight chamber will be used instead. It not only provides 
electrical contact, but also allows vacuum to be connected to draw sample during 
injection and separation (optional) steps. The on and off of the vacuum source can be 
controlled by an electronicallly actuated valve. The injection volume is controlled by 
both the vacuum level and the injection time.  
Combining the injection system described above with small bore surface 
derivatized capillary (20 m and below) and short length (less than 10 cm), this approach 










Figure 6-1. A Mechanism of flow-gated CE injection
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. B. Instrumental design of 
























One unique advantage of the flow-gated injection is the continuous flow sample 
introduction. This feature allows automated and high throughput sample introduction 
from micro-titer plates. Commercial CE instruments exclusively use a moving stage 
loaded with buffer that moves at every rinsing, injection and separation step. The 
mechanical movement not only takes time, but also increases the probability of 
instrument failure. Flow gated injection solves this problem by decoupling the sample 
introduction and CE separation, which should enhance system reliability in addition to 
sample throughput.   
Droplet Microfluidics and Chip Based CE 
CE consumes only a few nano-liter volume samples or lower, which could 
potentially lead to significant reagent saving in large scale HTS. However, commercial 
instruments typically require at least 10 L sample volume to initiate the analysis. 
Segmented flow coupled micro-chip CE can be a promising alternative to realize the full 
miniaturization potential of CE. In this approach, library compounds stored in a multi-
well plate can be reformatted into oil segmented fluid plugs stored in a piece of tubing 
(Figure 6-2A). After sampling and reagent addition, the segmented flow content will be 
extracted into a continuous aqueous phase and analyzed by CE-LIF via devices depicted 







Figure 6-2. (A) Samples stored in multi-well plates can be re-formatted into oil-
segmented fluid plugs using a syringe pump to draw aqueous samples and fluorinated oils 
as alternating fluid plugs in a piece of Teflon tubing. These sample plugs can be further 
manipulated and analyzed by CE.
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 (B) Coupling segmented flow to a traditional flow-
gated CE setup
53
; C. microfluidic devices can be fabricated to extract and analyze 












Preliminary results suggest that the schemes shown in Figure 6-2B and 2C are 
able to increase the throughput of CE assays to over 10,000 assays per day, meeting the 
requirement of HTS. Future work in this area will involve development of surface 
modification techniques that is compatible with the micro-chip fabrication process.  
Label Free Detection 
The assay described herein used fluorescently labeled protein and LIF detection. 
LIF has best sensitivity and simplifies the data interpretation. One concern with this 
fluorescence detection though is that labeling may interfere with the binding if they 
happen to be at the protein binding site or change protein’s allosteric property. The assay 
can be fully validated if the labeling site is carefully identified and affinity studies 
suggest the protein behave the same as without the fluorescent tag. Still, label free 
detection will make CE more generic to PPI targets and simplify the method development  
Two “label free” detection schemes are considered here. The first approach is 
post-column derivatization coupled to LIF detection. As mentioned in Chapter 5, in the 
post-column derivatziation mode, native proteins are separated as they are and labeling 
and fluorescence detection happens after separation. Sensitive detection can be achieved 
without labeling proteins in the first place. Coupling CE to post-column derivatzation and 
LIF detection has been demonstrated previously and Figure 6-3 A illustrates one of the 
many configurations of CE coupled to post-column derivatization. The drawback is that 
the detection step provides very limited selectivity of analytes been separated. Unlike the 




fluorogenic reagents will be detected. It can be expected that the post-column mode will 








Figure 6-3. A. Post-column derivatization and LIF detection setup for CE separation of 
intact proteins.
135
 (B) A sheath flow CE-ESI-MS system
136
. C. MS detection of APCE 
separation of PPIs. 
Another promising alternative is Mass Spectrometry detection. With soft 
ionization techniques such as ElectroSpray Ionization (ESI) and Matrix Assisted Laser 
Desorption Ionization (MALDI), liquid phase biomolecules such as proteins can be 
converted into charged gas phase ions that are analyzed by various mass analyzers to 
obtain molecular weight and some quantitative information. Coupled to separations such 
as LC and CE and used as a detector, MS not only serves as a universal and sensitive 
detector, but also adds much specificity to the detection scheme due to the high resolution. 
CE-MS has also been demonstrated with a variety of different analytes including 
intact proteins. By coupling MS detection to affinity CE studies, the labeling problem can 
















MS Signal for One Protein





analytes also allows additional information and confidence in detecting binding events 
(Figure 6-3C). Challenges of top down proteomics are also the major concerns with this 
approach. MS, by and large still has limited dynamic range and inadequate resolving 
power for intact proteins. Only the most state of the art MS hardware has the promise of 









LIST OF 18 COMPOUNDS TESTED IN CE SECONDARY ASSAY 
Compound Number Compound Name 
1 Homidium Bromide 
2 Methylergonovine maleate  
3  Levodopa  
4  Laudanosoline  
5  5-Aminosalicyclic acid 
6 Methyldopa 
7 Tanshione IIA 
8 Oxytetracycline  
9 NCl16221 
10 FK866 
11 Pyrvinium pamoate  
12 Carminic acid 
13 Captopril   
14  EGCG  
15 Cortisone  
16 Meclocycline sulfosalicylate   
17 Purpurogallin  







LIST OF COMPOUND #9 AND ITS STRUCTUAL ANALOGUES 




9A Anthraquinone-2 6-disulfonic acid 
9B 9B: Anthranrufin 
9C 9C: R494291 
9D 9D: JFD00244 
9E 9E: 2,2′-Iminodibenzoic acid 
9F 9F: 1-(Methylamino)anthraquinone 
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